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I have been a registered dietitian since 2003 and over the course of my career I have worked in a wide 
variety of settings and a range of clinical areas.  I currently work as a rural generalist dietitian in Central 
Otago and over recent years I have developed a particular interest in gastrointestinal conditions.  I get a 
lot of satisfaction working with people for whom diet plays such an important part in managing their 
chronic conditions. 
This project arose after discussions between myself and Professor Michael Schultz whereby the need for 
New Zealand (NZ) research in dietetics in inflammatory bowel disease (IBD) was identified.  Dr Catherine 
Wall (NZRD) became involved in discussions at this point as this is her specialty research area.  As a group 
it was decided to explore the topic of dietetic services for patients with IBD in NZ and the research 
proposal was developed with Dr Wall and Professor Schultz as my supervisors. 
I hope that this thesis will raise the profile of diet in IBD treatment and management and highlight the 
benefits of a greater role for dietitians in the IBD multidisciplinary healthcare team.  It will be of interest 








Inflammatory Bowel Disease (IBD) is a chronic disease affecting increasing numbers of New Zealanders.   
Diet therapy plays an important role in disease treatment and management.  This research project was 
designed to evaluate dietetic services in IBD care in New Zealand (NZ).  
Aims 
To investigate IBD patients’ experiences of dietetic services; evaluate the capacity of the NZ 
gastroenterology dietitian workforce; assess gastroenterologists’ experience of NZ IBD dietetic services 
and investigate differences in dietitian access for patients living in rural versus urban areas. 
Methods 
Online surveys of patients, dietitians and gastroenterologists were conducted in early-mid 2020. 
Quantitative data was analysed for statistical significance by non-parametric tests with a p-value <0.05 
regarded as statistically significant. Qualitative data was analysed by thematic analysis.  
Results  
Responses were received from 407 IBD patients, 79 dietitians and 40 gastroenterologists.  Half the 
patients (52%) had seen a dietitian for IBD nutrition advice.  Patients more likely to have seen a dietitian 
were/had: Crohn’s disease (p=0.001), previous IBD surgery (p<0.001), younger (p<0.001) or receiving 




(p=0.0001).  There was a non-significant trend towards greater numbers of patients from urban areas 
having seen a dietitian than patients from rural areas. 
Two-thirds (66%) of patients found the dietitian advice at least moderately useful while 18% did not.  
Patients who saw a dietitian in a private clinic were more likely to find the advice useful (p=0.0001), as 
were those who had received written advice (p<0.0001).  A common theme from qualitative data was the 
need for dietitians to have specialist knowledge of IBD. 
Almost all (97%) gastroenterologists reported that their IBD patients ask about nutrition; 57% reported 
that there were not enough dietitians to meet patient needs.  Over 50% of dietitians saw IBD patients 
infrequently and 39% were not confident that they are up to date with the nutritional management of 
IBD.  Nearly 80% would require changes to their dietetic service to allow higher numbers of IBD patients 
to be seen.  Dietitians wished to have greater links to the IBD multidisciplinary team (MDT). 
Discussion 
International IBD management guidelines recommend that all patients with IBD should have access to 
dietetic support and nutrition therapies 1-3.  NZ patients clearly do not have adequate or equitable access 
to dietetic services; patients wish to have ongoing dietitian access to address nutrition needs that may 
vary over time.  Dietitians acknowledge the need for additional upskilling in the nutritional management 
of IBD.   
Conclusion 
The project achieved its key aims and concluded that current IBD dietetic services in NZ are inadequate.  
Increased resourcing of dietetic services and stronger links to the IBD MDT will ensure that nutrition 
therapy is evidence-based, collaborative and implemented in a timely manner.  While some dietetic 
services already provide care at this level, further work is needed to guarantee that access to quality and 
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Chapter One Introduction 
1.1 Background 
Crohn’s disease and ulcerative colitis are the most common forms of IBD, a chronic gastrointestinal 
disease affecting increasing numbers of New Zealanders 4.  These are life-long conditions whereby chronic 
inflammation in the gastrointestinal tract causes symptoms such as diarrhoea, abdominal pain, rectal 
bleeding, weight loss, nutrient deficiencies and intestinal strictures.  In ulcerative colitis inflammation 
begins in the rectum and extends for a variable distance but is limited to the colon 1.  Crohn’s disease can 
affect the entire gastrointestinal tract from mouth to anus, particularly affecting the small bowel 1.  The 
presentation and disease-course of IBD varies greatly from one person to another and requires specialist 
gastroenterology management.  IBD can have an enormous impact on patients, with periods of remission 
followed by acute relapses throughout their lives for many people 1. 
Whilst IBD is considered an inflammatory autoimmune disorder, it is increasingly acknowledged that 
environmental factors play a role in its development.  International data indicates that while incidence 
rates in developed countries are stabilising or falling, the overall prevalence of IBD is increasing 5.  While 
prevalence of IBD is higher in developed countries, incidence rates in developing countries are increasing 
as lifestyles become more ‘Westernised’, although the exact contributing factors for this remain unclear 
5, 6.  IBD can be diagnosed at any age, but it is most commonly diagnosed in young people before the age 
of 30 7.  
Diet therapy plays an important role in IBD treatment and management 8, and as such, the United 
Kingdom and Australian IBD national standards recommend a multidisciplinary approach that includes 
dietitians to management of IBD.  Both standards recommend 0.5 full time equivalent dietitians dedicated 
to adult gastroenterology, including time allocated to IBD, per 250 000 population 3, 9.  NZ lacks a similar 
document to guide standards of care.   
No audit has been undertaken in NZ to evaluate gastroenterology dietetic services or to evaluate IBD 




about their experiences with IBD and the NZ healthcare system 10.  The report found that an appointment 
with a dietitian was not routinely offered unless the patient requested it, or a specific nutrient deficiency 
was diagnosed.  Patients indicated that more information about what they should eat to help manage 
their IBD would be useful as diet is one of the few things they can control 10.  This research project was 
designed to evaluate these issues more comprehensively and provide recommendations for future 
dietetic service provision and potential improvements to better meet patients’ needs. 
1.2 Aims and significance 
It is estimated that over 20 000 New Zealanders are diagnosed with IBD 11.  While there have been 
anecdotal reports of inadequate and inequitable patient access to dietitians in NZ, there has been no 
strong data to support this 10.  The researchers hypothesised that: access to dietetic services was 
inadequate; access was poorer in rural areas; and that many dietitians seeing IBD patients were not 
confident they were up to date with nutritional management of IBD.  This thesis was designed to 
investigate whether these hypotheses were correct and what the reasons for this may be.  Thesis 
outcomes may help inform future healthcare planning. 
The project had four aims: 
1. To investigate NZ IBD patients’ experiences of dietetic services, including who has had access to services 
and whether services met their needs and expectations. 
2. To evaluate the capacity of the NZ gastroenterology dietitian workforce, including their current 
workload related to IBD, ability to manage potentially increasing numbers of patients with IBD and their 
self-perceived knowledge and skill level in the nutritional management of IBD. 
3. To assess gastroenterologists’ experience of NZ IBD dietetic services. 
4. To investigate whether differences existed in access to dietitians for patients living in rural areas versus 




Chapter Two Literature Review 
2.1 IBD in New Zealand 
No nationwide IBD prevalence study has ever been undertaken in NZ although there have been regional 
prevalence studies.  An early incidence study of ulcerative colitis (UC) was undertaken in the lower part 
of the North Island in 1960 12.  This recorded approximately five incident cases of UC per 100 000 
population per annum, with very few Māori patients identified over a ten-year period 12.  Public hospital 
data collected in Auckland between 1969-1978 identified 456 patients with UC and 137 with Crohn’s 
disease 13.  Only two patients were Māori.  At the time the annual incidence rates observed were 
significantly lower than North American and European rates 13. 
More recently, Dunedin researchers completed an 18-year epidemiological analysis of IBD incidence in 
the Otago region of NZ 14.  Hospital event data and gastroenterology department records from Dunedin 
hospital were compiled and analysed for the period from 1996-2013.  Annual IBD incidence rates varied 
between 5.8 - 29.8 cases per 100 000 people.  The majority of patients self-identified as NZ European with 
only eight Māori patients diagnosed over the 18 years 14. 
In Canterbury, NZ two incidence studies have been completed, one in 2004 15, another in 2014 4.  These 
studies used the same methodology, which allowed observation of changes in incidence over a ten-year 
period.  Incidence rates of IBD increased by 1.6-fold over the ten years, to a crude rate of 39.8 per 100 
000 people in 2014, one of the highest rates ever reported in the world.  Although national data do not 
exist, it is clear that rates of IBD in NZ are increasing.  Five years ago a report estimated that approximately 
21 000 New Zealanders were living with IBD and based on incidence rates, numbers of IBD cases were 
expected to double between 2017-2026 11. 
2.2 The role of dietitians in healthcare 
The NZ Dietitians Board defines dietitians as registered health practitioners who ‘use their dietetic 




policy, undertake research, manage and advise within a food environment, design nutrition programmes 
and apply best practice in medical nutrition therapy settings’ 16.  In NZ, dietitians are the only nutrition 
health professionals regulated by the Health Practitioners Competence Assurance Act (2003), requiring 
enrolment in the Dietitians Board Continuing Competency programme and possession of an annual 
practising certificate.  NZ dietitians with a prescribing endorsement have authority to prescribe a range of 
funded nutrition-related medicines and special foods. 
Dietitians have many and varied roles.  In clinical healthcare they work in hospitals, community outpatient 
settings, private practice, primary care, aged care and in healthcare foodservice provision.  Dietitians 
evaluate scientific evidence about food and nutrition in states of health and disease and translate this into 
practical strategies individualised for each patient.  Dietitians counsel patients on lifestyle modification to 
improve biochemical, physical and functional outcomes.  In acute and chronic health conditions, dietitians 
assess and manage malnutrition in its various forms, guide therapeutic diets, prescribe enteral and 
parenteral feeding and modified texture diets and advise on specialised post-surgery dietary modification.  
Dietitians often form part of a healthcare team, working in collaboration with other health professionals 
alongside patients.  Nutrition interventions can maximise the benefits of medical and surgical treatment 
and reduce the requirements for other interventions, with potential cost savings and positive impact on 
quality of life 17-20. 
2.3 Dietitians and IBD 
Dietitians play a key role in the IBD healthcare team, as attention to patients’ nutrition is an important 
aspect of treatment and management.  Nutritional status in IBD can be affected by IBD subtype, 
nutritional intake, medication, inflammatory status, nutrient absorption, excessive nutrient losses, 
increased metabolic and micronutrient requirements and prior intestinal surgery 21.  Malnutrition is a 
common problem in both paediatric and adult IBD patients 22-27.  Impaired nutritional status is linked to 
increased risk of IBD flares and higher clinical activity as well as impaired growth in children 23, 28.  For 
these reasons, international guidelines recommend that IBD patients receive nutrition support and that 




This chapter will review literature on the role of dietitians in IBD treatment and management, the impact 
of dietary therapies and nutrition interventions on IBD outcomes, the benefits of including dietitians in 
the IBD MDT, and IBD patient access to specialised dietetic care and evidence-based nutrition information. 
2.4 Nutrition and IBD 
Nutrition is an important aspect of the treatment and management of IBD 21.  Malnutrition is highly 
prevalent in both paediatric and adult IBD patients 22-26 and over the past ten years the importance of 
nutrition screening and assessment in IBD patients has been commonly discussed 22, 25-27, 30-33.  More 
recently, standard adult malnutrition screening tools have been modified to develop IBD-specific 
screening tools that more accurately reflect the areas of nutrition risk for IBD patients 24, 34.  
Malnutrition screening is not consistently carried out as part of routine IBD care, meaning malnutrition is 
often not recognised and malnutrition rates are underestimated 35, 36.  Once a patient is identified as being 
at nutritional risk, it behoves clinicians to intervene appropriately, which in most cases should involve 
referral to a dietitian for nutritional assessment and intervention.  Unfortunately, the frequency with 
which gastroenterologists (GIs) refer to dietitians is often low 35, 37 even though the benefits of nutrition 
therapy in the treatment and management of IBD are well documented 1, 21, 33, 38-40.  Recently there has 
been growing awareness of the use of exclusive enteral nutrition (EEN) to treat active Crohn’s disease 
(whereby dietary requirements are exclusively provided by liquid nutrition in the form of a medical 
formula), but there is also increasing interest in other dietary therapies used alongside medical and 
surgical interventions 41, 42 43.   
2.4.1 Exclusive enteral nutrition in IBD 
As early as the 1960s there was interest in using EEN in the treatment of IBD 44, 45.  Whilst early studies 
used enteral nutrition in conjunction with medication, by the 1980s and 1990s research showed that EEN 
could be as effective as steroid therapy at achieving remission in Crohn’s disease 46, 47.  Some research was 
affected by high dropout rates in patients treated with EEN, often due to the low palatability of amino 




and are just as efficacious in achieving remission 50 so are now the preferred choice of formula in most 
parts of the world, although elemental formula is still used in Japan 51.   
In children, EEN is the recommended first line therapy for the treatment of newly diagnosed Crohn’s 
disease, with higher rates of mucosal healing and improved nutritional status when compared with steroid 
therapy 21, 39, 52, 53.  EEN avoids the deleterious side-effects of steroids, such as hyperglycaemia, decreased 
bone mineral density and growth suppression 54.  Although widely recommended, there remains some 
variation in rates of use around the world, with greater use in Europe, Australasia, Japan and Canada than 
the USA 55-57.  Evidence for the use of EEN in adults with Crohn’s disease is not as strong as it is in children.  
However, it is successfully used as first line therapy in Japan 51, 58 and is recommended in many guidelines 
either as first line therapy, or as an option for patients who wish to avoid steroid therapy or who do not 
tolerate IBD medication 1, 21, 38, 48, 59.  Despite these recommendations, EEN is not yet widely used in adults, 
neither in newly diagnosed patients nor those with existing active disease 48.  A survey of NZ GIs’ 
knowledge and practice with EEN to treat Crohn’s disease found that while 90% of respondents were 
aware of EEN as a treatment option for patients with active Crohn’s disease, only 33% of physicians with 
adult patients had used the therapy in the past twelve months 60.  A qualitative study in Australia 
interviewed 17 adults about their experience with EEN and found that patients experienced emotional 
and physical benefits from this treatment strategy 61.  Patient self-efficacy, health system support and 
accessibility of nutritional formulas were all identified as key enablers for adherence to EEN treatment 61.  
An Australian and NZ working group recently developed an optimal care pathway and patient resource to 
standardise care and facilitate increased use of EEN in adults with active Crohn’s disease 43.   
2.4.2 Whole food diets and IBD 
While the exact mechanisms of action are uncertain 59 it is theorised that EEN works by providing adequate 
nutrition, whilst eliminating dietary components that contribute to gut inflammation 62.  The effect on the 
microbiome is believed to be an important factor contributing to the success of EEN 59, 63.  This has 
stimulated interest in developing dietary therapies based on foods that can replicate the benefits of EEN 
63, 64.  It is considered that dietary therapy based on food rather than medical formula may increase 




Multiple articles over the last five years have reviewed the link between diet and IBD and made a variety 
of dietary recommendations 40-42, 62, 66-73.  Various exclusion diets to treat IBD have been researched and 
trialed around the world, often in small sub-groups of IBD patients, all with the aim of inducing or 
maintaining remission 74-80.  These include an anti-inflammatory diet, a diet based on specific types of 
carbohydrate, a semi-vegetarian diet, a low fat and low fibre exclusion diet, a diet designed to manipulate 
the omega-3/omega-6 polyunsaturated fatty acid ratio and an IgG-4 guided exclusion diet.  All diet 
interventions showed some success with patients, despite often contradictory dietary rules across the 
different treatments 62.  Further research is ongoing with several dietary interventions which will help to 
build a clearer picture of which dietary therapies are most effective and why 81.  The following sections 
summarise the available literature on two dietary treatments, the first because it is popular with patients 
and the second because it is showing potential as a treatment for active Crohn’s disease that may induce 
remission at similar rates to EEN.  
2.4.2.1 The Specific Carbohydrate Diet 
The Specific Carbohydrate Diet (SCD) was popularised by Elaine Gottschall in her book ‘Breaking the 
Vicious Cycle’ 82.  The diet excludes many processed foods, all grains, some high starch vegetables, free 
sugars except for honey and all dairy except some hard cheeses and lactose-free yoghurt.  The full SCD is 
recommended to be followed for a year to treat active disease, then a further 12 months after symptoms 
disappear before foods are gradually reintroduced.  If any return of symptoms occurs, it is recommended 
to recommence the full elimination diet.  It is targeted at people with a wide range of gastrointestinal 
diseases, as well as being promoted as a treatment for autism.  The diet is based on the theory that while 
monosaccharides are easily absorbed in the intestine and are therefore allowed in the diet, disaccharides 
and polysaccharides are not easily broken down and contribute to proliferation of bacteria and fungi in 
the gastrointestinal tract, causing mucosal damage and intestinal disease 82.   
While the diet has been popular with IBD patients, it has not been widely endorsed by medical and dietetic 
professionals 75 with concerns regarding lack of evidence of efficacy and potential nutritional inadequacy.  
A systematic review published in 2017 reviewed 8 observational studies of the SCD as a treatment for 
Crohn’s disease 74.  The reviewers concluded that while the overall quality of studies was low, with small 




measured by reduced symptom scores or improved laboratory measures of inflammation 74.  A further 
small study (nine participants) was conducted at Seattle Children’s hospital to assess the effect and dietary 
adequacy of the SCD for children with active Crohn’s disease or ulcerative colitis 75.  Most participants 
(7/9) experienced clinical improvement after 12 weeks following the diet.  While there were concerns 
about low average levels of calcium, vitamin D, thiamine, folate and phosphorus provided by the SCD, 
these were similar to dietary data observed in larger population surveys.  The researchers concluded that 
the SCD should only be implemented in a supervised setting with multidisciplinary oversight from a 
physician and dietitian and may require multivitamin and mineral supplementation to ensure nutritional 
adequacy 75. 
2.4.2.2 Crohn’s Disease Exclusion Diet 
The Crohn’s Disease Exclusion Diet (CDED) is a whole-food diet designed to reduce exposure to dietary 
components which have been hypothesised to contribute to gastrointestinal inflammation and dysbiosis.  
It is used for the treatment of active Crohn’s disease 64.  For six weeks, participants on CDED receive 50% 
of nutritional requirements via a medical formula (partial enteral nutrition – PEN), plus remaining calories 
from a whole foods diet which includes five mandatory foods and allows limited other (mostly fresh) 
foods, and excludes food additives, wheat, dairy products, red or processed meats and high fat foods.  
After six weeks, a slightly wider range of foods is introduced with formula intake reduced to 25% of calorie 
intake.   
A recent multi-centre randomised controlled trial evaluated CDED + PEN and compared this to EEN in 
treating children with mild-moderate luminal Crohn’s disease 64.  Patients in the EEN group had their full 
nutritional requirements provided by medical formula for six weeks, with 25% of calories from formula 
between weeks six to twelve with a gradual return to normal diet over this six-week period.  Researchers 
found that the CDED + PEN intervention was better tolerated by patients, with greater numbers of 
patients completing the dietary therapy, and was more effective at achieving corticosteroid-free 
remission and reduced inflammation after twelve weeks.  It was hypothesised that the re-exposure to 
inflammatory components in the habitual diet after the initial six weeks of EEN caused rebound of 
inflammation and a loss of remission in those who were not on the CDED intervention 64.  A subsequent 




PEN.  Both treatments successfully induced remission in over 60% of patients by week six 83 indicating that 
this is a possible treatment option for adults as well as children.  
2.4.3 Adjunct nutrition interventions 
A systematic review found that around 35% of patients with quiescent IBD experience functional 
gastrointestinal symptoms 84.  The low FODMAP (fermentable oligosaccharides, disaccharides, 
monosaccharides and polyols) diet, initially designed to treat symptoms of irritable bowel syndrome (IBS) 
has proven effective at reducing symptoms in these patients 85, 86.  A recent single-blinded randomised 
controlled trial allocated IBD patients with quiescent disease but functional symptoms to receive either 
low FODMAP dietary advice or placebo advice from a dietitian.  After four weeks, patients who trialed the 
low FODMAP diet had experienced significantly reduced symptom scores and improved health-related 
quality of life compared with patients given placebo diet advice, although there was no effect on 
inflammatory markers 86.  Some differences in faecal microbiome were observed after the diet 
intervention, similar to those observed in other low FODMAP diet trials.  The researchers emphasised the 
requirement for the low FODMAP diet to be expertly managed with intensive follow-up and to take 
caution with longer-term use of the diet 86.  
Malnutrition is common in IBD patients and is linked to worse disease outcomes 22, 23.  A Spanish study 
found that malnourished patients were more likely than well-nourished patients to avoid food groups due 
to fear of IBD symptoms and that malnutrition was linked with greater IBD clinical activity 23.  Malnutrition 
can present as low body weight or poor growth, but even in patients of higher body weight, as lower fat 
free mass or decreased strength 23.  Deficiencies of micronutrients including iron deficiency anaemia are 
also common in IBD patients 66, 87-89.  Dietitians can advise patients on dietary strategies to avoid and treat 
malnutrition and prescribe supplements to address protein-energy malnutrition and micronutrient 
repletion.  IBD patients are at higher risk of osteoporosis than the general population as a result of factors 
such as nutrient malabsorption, dietary restrictions, side effects of medications and low body mass 90.  
Nutrition is a key modifiable risk factor for osteoporosis, with implementation of dietary strategies shown 




The European Society for Parenteral and Enteral Nutrition recommends nutrition support for patients who 
undergo surgery for IBD irrespective of their prior nutrition status 8, 21.  Pre-operative enteral nutrition 
interventions improve nutritional parameters and post-surgery outcomes compared with those who do 
not receive this level of nutrition support 18, 91, 92.  Dietitians can play an important role in planning and 
implementing these interventions. 
One of the more commonly recommended diets in IBD is the low residue diet, even though there is no 
universally agreed definition and it is not supported by evidence of efficacy 21, 38, 93.  In theory, it may be 
useful to reduce the risk of mechanical obstruction in stricturing Crohn’s disease although there are no 
clinical trials on which this theory is based.  There is no evidence to support the widespread use of the low 
residue diet in IBD patients 21, 38 and long-term, unnecessary restriction of dietary fibre may increase the 
risk of Crohn’s disease flares 94. 
While much dietary research is focused on Crohn’s disease, a study to explore the effect of comprehensive 
dietary advice for ulcerative colitis found that those who received targeted education from a dietitian 
experienced reduced symptoms compared with patients in a control group 95.  Preliminary results of a 
recent low fat, high fibre dietary intervention in ulcerative colitis improved quality of life and gut 
microbiome diversity in a group of American patients 96.   
Dietary therapies in IBD can induce and maintain remission, improve functional symptoms and quality of 
life, address malnutrition, reduce disease-related complications and improve surgical outcomes. There is 
growing evidence that dietary therapies are an important part of IBD care. 
2.5 Dietitians in MDTs 
It is clear from the literature that research in the arena of diet and its effects on Crohn’s disease and 
ulcerative colitis is evolving rapidly.  This growing emphasis on dietary therapy in IBD, and the complexity 
of evidence-based dietary recommendations, highlights the need for dietitians to be involved in the MDT 
caring for IBD patients.  There are many examples of positive health outcomes that can be achieved when 
dietitians are included in a wide variety of MDTs, including teams managing Type 2 diabetes, bariatric 




In an alternative model of care, a dietitian-led gastroenterology clinic for irritable bowel syndrome 
patients improved patient health outcomes measured by symptom severity and quality of life scores 17.  
Patient referrals were screened by a consultant GI and those who met identified criteria were triaged to 
the dietitian-led clinic.  The clinic successfully reduced patient waiting times before first assessment by 
the gastroenterology service and achieved excellent patient satisfaction 17.   
The evidence indicates that dietitians play a valuable role in MDTs across a wide range of health 
conditions, with the ability to positively impact patient outcomes as well as improve healthcare services. 
2.6 IBD MDTs 
MDTs for IBD patients have been discussed and recommended for many years 103, 104.  Several best practice 
IBD management guidelines now recommend coordinated MDT care models 1-3, 9, 29.     
It is apparent from the literature that in practice opinions on what constitutes an IBD MDT differ.  Ricci et 
al stated that an IBD team should ‘ideally involve GIs, surgeons, pathologists and radiologists with a 
specific interest in IBD possibly with the support of dermatologists and rheumatologists’ 105.  A recent 
study surveyed 24 specialists with recognised expertise in IBD (GIs, surgeons, nurse-specialists, 
radiologists, histopathologists) regarding their views on the aims, function and format of an IBD 
multidisciplinary team 106.  There was unanimous consensus that GIs, colorectal surgeons, radiologists and 
nurse specialists are essential members of the IBD team.  Most agreed that histopathologists (21/23) and 
coordinators (21/24) are core members of the team but only 14/23 agreed that dietitians constitute core 
members of the IBD MDT.  Some respondents (8/23) considered that dietitians should be ‘extended’ 
members of the MDT, expected to contribute to the MDT when invited by a core member.  There was no 
explanation as to why participants considered health professionals to be ‘core’, ‘extended’ or ‘non-
members’ of the IBD MDT 106.   
A systematic review of the roles of healthcare professionals in the management of chronic gastrointestinal 
diseases, including IBD, found that GIs and nurses are the predominant health professionals involved in 
IBD management 107.  However, many studies identified other types of health professionals involved 




practitioners and physiotherapists.  The review concluded that there is potential for primary care 
providers to play a more active role in IBD management 107. 
In an opinion piece, Lawrance suggested that the ‘MDT is central to the optimal management of the IBD 
patient’ 108.  He recommended that IBD team meetings should occur on a minimum of a fortnightly basis 
to discuss IBD patients with complex needs, with all team members attending these meetings.  He stated 
that all IBD units should aspire to having an MDT that includes gastroenterology, colorectal surgeon, IBD 
nurse, dietitian, psychological support, stoma therapist, radiologist and histopathologist 108. 
A 2014 international survey of IBD health professionals found that most respondents would ideally prefer 
to be part of a fully integrated specialist IBD service, with input from physicians, nurses, psychologists and 
dietitians for all patients, with a wider team available when necessary 109.  However, they reported that 
this was rarely the model of care in their respective centres, mainly due to funding constraints 109.  A 
Canadian survey found a wide variation in the median full-time equivalent (FTE) positions of all allied 
health professionals at different paediatric IBD tertiary care centres; the range of gastrointestinal dietitian 
FTEs at the centres varied from 0 – 1.0 FTE with a median of 0.5 FTE 110.   
In general, where IBD MDTs have been evaluated, results have been positive for patients and healthcare 
services, with desirable outcomes such as decreased hospital admissions, decreased disease scores and 
increased cost efficiencies 111-113.  Lee and Melmed suggested that different models of MDT care would be 
appropriate in different healthcare settings 114.  They acknowledged the benefit of specialist nutrition and 
other ancillary care in IBD but stated that economic constraints can make it challenging to implement full 
multidisciplinary care within a single setting 114.  Despite widespread international acceptance of the role 
of nutrition in IBD management and evidence of positive outcomes from MDTs which include dietitians, 
nutrition is not currently emphasised in IBD management guidelines or patient resources in the United 
States of America 115, 116. 
Clearly, dietitians working in MDTs across many different health conditions can positively contribute to 
health outcomes and patient experience of healthcare.  Dietitians are the obvious health professional of 




extensive training in medical nutrition therapy and dietary counselling and the only regulated health 
professional required to maintain competencies in these areas.  While some aspects of basic diet advice 
can be provided by other members of the healthcare MDT, specialised dietary therapy to treat IBD such 
as enteral nutrition, exclusion diets, nutritional supplementation or interventions to manage IBD 
symptoms such as fibre or macronutrient modification should be carried out by dietitians, who have the 
skills and expertise to modify recommendations to individuals’ personal circumstances and where 
necessary, will take into account co-existing medical conditions.      
2.7 Dietitians and nutrition in IBD care in NZ 
It appears that few NZ IBD clinics use an MDT approach which includes a dietitian as standard practice.  A 
2008 survey of NZ adult GIs had 51 replies, a response rate of 94% 37.  The topic of the survey was GIs’ 
practices regarding dietary advice in IBS and IBD.  Almost all respondents (96%) stated that they had access 
to dietetic services but only 29% had access to specialist gastroenterological dietetic services, most having 
access to general dietetic services instead.  Physicians were asked how many dietetic hours were allocated 
to their service, but more than half of respondents did not answer this question.  Of the 21 respondents 
who answered this question, the responses varied from 1-20 hours (presumably per week, although this 
wasn’t stated) with a median of four hours.  This survey was also distributed to GIs in the United Kingdom 
(UK).  UK physicians reported greater access to dietetic services, greater access to specialist 
gastroenterological dietetic services and higher allocated dietetic hours (median of six hours, range of 0-
100 hours) than NZ physicians.  Both NZ and UK physicians reported that they refer fewer than 25% of IBD 
patients to dietetic services 37.  
A 2016/2017 NZ audit of outpatient IBD standards of care found that across the 21 NZ District Health 
Boards (DHBs), only three had a full MDT including GI, colorectal surgeon, clinical nurse specialist with 
competency in IBD, stoma therapist and dietitian dedicated to gastroenterology 117.  Fewer than 2/3 of 
DHBs had regular MDT meetings, always with a GI and specialist nurse in attendance but a dietitian 
attending at only 20% of DHBs 117. 
NZ GIs were also surveyed in 2015, this time about their perception, knowledge and experience of using 




survey reported almost always considering EEN therapy for children newly diagnosed with Crohn’s 
disease, a lower percentage of adult GIs used this therapy.  For adult GIs to be more likely to use EEN, 
they required better multidisciplinary support, alongside improved evidence and clinical practice 
guidelines 60.  Similarly, in Australia, a survey of physician perspectives on the use of EEN in paediatric IBD 
identified that physicians believe that dietitians play a crucial role in the successful implementation of this 
treatment strategy 118.  There were varying rates of use of EEN by different physicians, however the survey 
did not address the question of whether dietitian access in their centres contributed to their decision 
whether to use EEN. 
NZ dietitians report varied levels of experience and confidence using EEN to treat Crohn’s disease in a 
2017 survey 119.  Dietitians working with paediatric patients were more likely to have used EEN than those 
working with adults, but most dietitians had only used EEN with a handful of people, with a median of 
three patients (range 0-50 patients).  Only ten NZ dietitians had used EEN in five or more patients.  It was 
observed that NZ dietitians have a low exposure to Crohn’s disease patients overall, with the survey results 
suggesting that dietitians see only a small portion of the NZ Crohn’s disease population, despite this being 
a group of patients at high nutrition risk 119.  A more recent survey of NZ and Australian paediatric dietitians 
who work in teams using EEN in Crohn’s patients, found wide variation in the number of patients seen for 
this treatment each year (5-40 patients) as well as variation in the hours spent working with IBD patients 
per week (1-40 hours) 120.  While these studies surveyed dietitians’ experience with EEN, it is unknown 
what other types of dietary strategies and advice are offered by NZ dietitians to IBD patients. 
2.8 Patient experience of healthcare in IBD 
IBD patients are frequent and long-term users of healthcare services because of the chronic and relapsing 
nature of their condition and because they are often diagnosed early in their lives 7, 29.  It is recognised 
that evaluating patient perspective is an important measure of the quality and performance of healthcare 
services 121.  Several groups have investigated IBD patient experience of healthcare services although 
these investigations did not always include evaluation of dietetic care 11, 35, 122.   
One study that did look at patient experience of nutrition care in IBD was carried out at the Guy’s and St 




IBD were recruited from an outpatient clinic.  They participated in a face-to-face interview with the aim 
of investigating the prevalence of nutrition problems in IBD and the extent to which these problems are 
addressed by healthcare services.  Many (62.5%) patients rated food and nutrition as important or 
extremely important in relation to their disease.  High numbers had experienced problems related to 
weight changes, lethargy, trigger foods, gut problems, food affecting social activities or micronutrient 
deficiencies.  Less than half (47%) of patients had seen a dietitian for advice about IBD and 82% of those 
who had not seen a dietitian would like to do so 123.  A patient survey at another NHS Trust found similar 
numbers (43%) of patients had seen a dietitian, although some of them had paid to see a dietitian privately 
124.  Most of those who had seen a dietitian (82%) found it beneficial but 24% of patients who had seen a 
dietitian within the Trust found the service poor or below average 124.  
A group of health practitioners developing an online dietetic consulting business conducted a survey of 
46 IBD patients and their views on dietetics 125.  About half the patients (52%) had seen a dietitian 
previously but only 20% of those had found this helpful, mostly due to seeing a generalist dietitian rather 
than one who had specialist IBD knowledge.  Patients reported that the most important factor to them in 
choosing which dietitian to see was the dietitian’s specialist IBD knowledge 125. 
In response to the publication of the first UK National Service Standards for IBD in 2009, (most recently 
updated in 2019 2) which stated that all patients should have access to a dietitian, the Derby Hospitals 
NHS Foundation Trust surveyed patients on their IBD database 126.  They received responses from 113 
patients, the majority of whom (79%) responded that they were unaware of any specific nutrition 
treatment options in IBD.  Most patients (85%) would like to see a specialist dietitian to discuss nutrition 
and IBD but only 34% of patients had been offered a dietitian appointment.  Patients had sought nutrition 
advice from a wide variety of sources including health professionals, the internet, magazines, health shops 
and books.  Half the patients followed a ‘special diet’ and 40% took nutritional supplements.  The authors 
commented that while dietetic support is available to patients, they are unable to self-refer, relying on 
other health professionals to refer them.  Some patients were likely to be unaware of the services 




A validated survey, the ‘Instrument to Evaluate the Experience of Patients with Chronic diseases’ was 
distributed to IBD patients from 25 Spanish hospitals 122.   Many of the respondents (73%) reported 
searching the internet and media for information on diseases, therapies and lifestyle or diet 122.  This 
suggests that diet is an important topic for patients but they may not be receiving adequate information 
from health professionals. 
An audit of the quality of care received by IBD patients admitted to Australian hospitals by Massuger et al 
35 found that many processes did not meet quality standards.  Related to nutrition, fewer than 40% of 
patients had a formal nutrition risk assessment during their admission and fewer than 50% of patients 
were reviewed by a dietitian.  Improved adherence to IBD standards was noted in hospitals which had a 
full or partial specialised IBD multidisciplinary service 35.  Another group of researchers set out to evaluate 
patient experiences against the same Australian IBD standards and similarly found shortfalls in the overall 
care received by IBD patients when compared to the standards 127.  Only 30.9% of the 731 patient 
respondents reported access to a dietitian.  Numbers with access to a dietitian were higher for those 
whose IBD care was managed by public hospital outpatient clinics (48.9%) 127. 
In NZ, the Crohn’s and Colitis New Zealand Charitable Trust commissioned a report titled ‘Reducing the 
Growing Burden of Inflammatory Bowel Disease in New Zealand’ 11.  The report found that access to 
quality IBD care in NZ was not equitable and depended on patients’ geographic location.  The report 
concluded that psychosocial and nutritional health can be neglected under the current healthcare system 
and that earlier and more effective interventions could significantly improve quality of life for patients 11.  
Research shows that IBD patients in rural areas experience even greater difficulties, and incur greater 
costs, accessing specialist health services than patients who live in urban areas 128, 129.  It has been 
suggested that greater use of telehealth and online technologies may assist in improving healthcare 
access, including to MDT members such as dietitians, for rural patients. 
It appears that IBD patient experience of healthcare internationally, including in NZ, does not always meet 
patient expectations and has considerable scope for improvement.  It is common for patients to wish to 




dietitians are not always satisfied with the advice provided, particularly if the dietitian does not have 
specialist knowledge of IBD nutrition. 
2.9 Patient knowledge and practices related to IBD and nutrition 
Patients believe that nutrition is an important factor affecting IBD and are often frustrated by a lack of 
access to reliable IBD nutrition information 36, 130-132.  A UK partnership of patients, healthcare 
professionals and a patient support organisation collaborated on a project to establish the ‘Top 10 
research questions in IBD’ 130.  Diet was a key factor related to four of the agreed research priorities 130.   
A survey carried out with members of the Crohn’s and Colitis Foundation of America found that 90% of 
Crohn’s disease patients and 84% of UC patients rated nutrition as ‘very important’ in their IBD care 36.  
Despite this, only approximately 35% of patients reported routinely discussing it with their health provider 
during a healthcare visit.  When patients were asked why they did not discuss nutrition more often with 
healthcare providers, some patients felt that their health professional did not have enough time to discuss 
this and over 20% felt that their provider lacked the necessary expertise in this area.  Patients were most 
likely to discuss nutrition with their GI, with fewer than 12% of patients having discussed nutrition and 
IBD with a dietitian.  A third of patients wished to discuss nutrition with a dietitian but were concerned 
that they could not afford to do so.  Another 20% planned to schedule an appointment to see a dietitian 
in the future.  As well as healthcare professionals, patients reported sourcing IBD nutrition information 
from the internet, social media, other patients, family members, magazines, books and television shows 
36.  The findings about patients searching for alternative sources of information were similar to those of 
other researchers 122, 133, 134.  
A study in the United Kingdom interviewed IBD patients on the quality of IBD nutrition information sources 
they had access to 131.  Seventy-two patients were interviewed about how health services addressed food 
and nutrition problems in IBD, particularly the access to, and quality of information they received.  
Patients noted how important it is to receive individualised information and made negative comments 
about the lack of sufficient nutrition information and its individualisation.  Fewer than 50% of the patients 




This study also surveyed dietitians and asked them to send copies of printed resources they used that 
were specific to IBD.  While most dietitians reported providing written nutrition information to patients 
with IBD, 49% of dietitians considered that there are gaps in IBD-specific patient resources.  The printed 
resources supplied by dietitians were evaluated against two validated assessment tools (the ‘British 
Medical Association Patient Information Appraisal Form’ and the ‘Ensuring Quality of Information for 
Patients’ tool).  The resources evaluated were considered variable in the quality of ‘general content’ and 
‘scientific content’, with some scoring poorly.  Commercially produced resources rated more highly, but 
there were some concerns about the lack of objective advice e.g. regarding choice of formula in EEN 131. 
Qualitative research carried out in the UK investigated ‘food-related quality of life’ in IBD patients and 
how health professionals address this 132.  Patients felt that food-related issues do not receive enough 
attention by health professionals who acknowledged that this is often a low priority in consultations.  
Some felt ill-equipped to address nutrition issues or that it was the role of other MDT members to do so 
132.  Further research by the same group confirmed the substantial effect of IBD on food-related quality of 
life 133.  Patients reported that their diagnosis of IBD affects their food choices e.g. decreased food intake 
due to nausea, pain and diarrhoea and also that their food choices affect their IBD, with many reporting 
that they restricted their diets in an effort to avoid triggering IBD symptoms.  Patients’ social lives were 
greatly impacted by their IBD due to food restrictions.  Many participants had received diet advice from 
their GI and/or a dietitian but the advice offered varied, as did satisfaction levels with the advice given, 
with some patients finding it superficial or confusing.  Despite trying to do so, some patients were unable 
to access a dietitian and patients reported seeking other sources of nutrition information, such as 
discussion groups or the Internet.  Satisfaction with these information sources also varied.  The lack of 
reliable, quality IBD nutrition information left patients struggling to find effective dietary strategies to help 
manage their IBD and patients felt that their food-related concerns were ignored by their healthcare team 
133. 
Similar sentiments were expressed by Australian patients surveyed in 2012, with 61% of IBD patients 
feeling that their IBD specialist did not place importance on the role of diet in IBD 135.  In contrast, 94% of 
GIs and 99% of dietitians agreed that diet was a factor in symptoms and 98% of GIs reported providing 




Casanova et al surveyed nearly 1300 Spanish IBD patients and found that food restriction behaviour was 
common and increased the risk of malnutrition, which was associated with higher rates of clinical IBD 
activity 23.  Canadian research found that food avoidance increased sharply during active flares of IBD and 
was higher in stricturing Crohn’s disease compared with non-stricturing disease or ulcerative colitis 136.  
Findings were similar in Polish parents of children with IBD, with 67% of parents believing that food can 
trigger an IBD flare and 65% reporting that their children avoid eating foods they enjoy because of fear of 
exacerbating their condition 137. 
NZ researchers surveyed 446 individuals with Crohn’s disease about foods they do or do not tolerate 138.  
A high degree of variability was noted in responses, with no single food regarded as tolerated by all 
participants and likewise no food universally regarded as not tolerable.  The majority of participants 
reported that they were able to reduce their IBD symptoms by making dietary changes 138.   
An Australian study investigated the rationale behind food avoidance in IBD patients in more depth 134.  
Structured interviews and nutritional assessment plus a review of medical records were carried out with 
117 patients.  Nearly all (90%) patients reported avoiding one or more foods or food categories because 
of their IBD, both during active disease flares and when in remission.  A range of foods were avoided for 
reasons including pain or more frequent bowel motions and diarrhoea when these foods were consumed, 
raising concerns about potential risk of nutritional deficiencies.  Three-quarters of patients interviewed 
had received dietary advice from a health professional, with 71% of participants also seeking dietary 
advice from other sources such as websites, online forums or books.  Confidence in the advice given by 
health professionals was generally low with participants with active disease having more confidence in 
advice sought from the internet than advice from health professionals.  Participants in remission had 
significantly greater confidence in advice provided by their GI than advice provided by dietitians or the 
internet 134. 
Evidently patients are interested in the effects of diet on IBD and consider it an important factor in 
managing their health.  Whilst members of the healthcare team generally appear to agree with this, it 
does not necessarily follow through to nutrition being prioritised as a topic in clinic consultations which 




frustration with the quality of advice offered by health professionals.  Work is required to increase patient 
access to quality, individualised nutrition advice and also to ensure that health professionals are 
adequately trained on latest evidence regarding nutrition and IBD.  This will ensure that patients have 
access to appropriate nutrition advice to maximise their nutrition status.  
2.10 IBD healthcare professionals’ nutrition views and practices 
American healthcare providers were surveyed as part of the earlier described patient survey 36.  Compared 
to the 84-90% of patients, much lower numbers of health professionals rated nutrition as very important 
in IBD management: 49% of GIs; 74% of nurses; and 80% of dietitians.  In contrast to concerns from 
patients about providers’ lack of nutrition knowledge, 84% of all healthcare professionals self-rated their 
knowledge on IBD nutrition as ‘very good’ or ‘good’.   
Focus groups held as part of the research found that while 87% of dietitians rated their knowledge of IBD 
nutrition as ‘very good’, they also acknowledged that their dietetic training does not specifically prepare 
them for IBD-related nutritional care.  Both physicians and patients expressed concern that not all 
dietitians have sufficient expertise to manage IBD-related nutritional issues, particularly if patients have 
complex IBD.  While most providers believed that only a small number of their IBD patients experience 
malnutrition, this contrasts with the views of patients participating in the focus groups, most of whom 
believed that they had been malnourished at some point during the course of their disease.  Overall, 
results from the surveys and focus groups point to discrepancies between patient and provider beliefs 
and experiences related to nutrition and IBD 36.   
A survey of the knowledge gaps of IBD healthcare providers (mostly doctors and nurses) in the United 
States found that they were comfortable in their ability to assess nutritional deficiencies and make dietary 
recommendations 139 and did not highlight nutrition as a knowledge gap requiring further professional 
education.  Gastroenterology dietetic services in England’s NHS were surveyed about provision of 
specialist gastroenterology dietetic care 140.  Most NHS dietetic departments reported providing a general, 
rather than specialised dietetic service for IBD patients, and of those trusts with a dedicated 
gastroenterology dietitian, higher numbers reported post-registration training in the management of IBS 




A recent national survey of IBD healthcare professionals in the UK 141 found inconsistencies in the nutrition 
advice offered by GIs, IBD clinical nurse specialists and dietitians.  53% of survey participants believed that 
diet could contribute to the likelihood of IBD relapse - healthcare professionals who had been working 
less than five years since qualification were more likely to believe this.  GIs and nurse specialists responded 
that they were ‘likely’ or ‘very likely’ to refer IBD patients to a dietitian, with 5% referring all patients to a 
dietitian 141. 
2.11 Summary 
The large numbers of IBD patients, including children, who avoid foods and food groups is of concern, as 
it increases the risk of malnutrition developing.  Impaired nutritional status is linked to increased risk of 
IBD flares as well as impaired growth in children 23, 28.  Dietary restrictions are often carried out without 
any supervision from health professionals, whom research indicates are not meeting the nutrition 
information needs of people with IBD.   
Patients wish to have specialised, individualised dietary advice from a health professional with a good 
understanding of their medical condition 125, 134.  In general, research indicates that greater numbers of 
IBD patients wish to see a dietitian than have had the opportunity to do so.  The limited amount of NZ 
research available indicates that NZ dietitians only see small numbers of IBD patients and access to IBD 
healthcare services is not equitable across the country.  Further research is required to more fully 
understand what the barriers are to NZ patients accessing dietetic services and whether patients who are 




Chapter Three Methods 
This chapter describes the development of the research surveys, survey dissemination, data analysis and 
ethical approval process chosen to achieve the research aims. 
3.1 Research Design   
Cross-sectional anonymous online surveys of patients, dietitians and GIs were chosen. The online surveys 
collected both quantitative and qualitative data to build a more complete picture of patient and health 
professional experiences and expectations of dietetic services in IBD.  While collecting quantitative data 
provides useful hard data regarding these topics, qualitative data helps to provide some explanation of 
results that emerge from the data. This was considered to be an important aspect especially as one of the 
thesis aims was to investigate IBD patients’ experiences of dietetic services in NZ. 
3.2 Survey development 
A multi-pronged approach was used to develop the survey questions.  Questions were initially drafted 
from themes that emerged from the literature review and centred around hypotheses developed based 
on the clinical experience and observations of the researchers.  The draft questions were then further 
developed and refined for the NZ context.  Two questions regarding patient confidence and trust in the 
dietitian/s they saw were based on the Picker Institute Europe’s report assessing patient experience of 
outpatient care in the NHS 142.  In the surveys an IBD multidisciplinary team (MDT) was described as a 
team which meets regularly to discuss IBD patients, or where several healthcare professions contribute 
to the development of a patient care plan, or where more than one health profession meets with the 
patient in the same clinic 3.   
Each survey was entered into Qualtrics software (SAP America Incorporated).  Questions had a 
combination of response types: multichoice, likert scale and free text.  Participants  were always given the 
option not to answer a question.  Branching was used in the surveys whereby participants were not asked 




their experience when seeing a dietitian; dietitians who did not see IBD patients were not asked about 
their nutrition assessment methods of IBD patients etc. 
When each draft survey was finalised, an electronic link suitable for distribution by email and social media 
was generated by Qualtrics software.  A participant who clicked on this link was taken to their survey and 
respond to the relevant questions.  No identifying data was collected; each response could be viewed 
separately or aggregated with other responses. 
3.2.1 Patient survey pre-testing 
The draft electronic survey was pre-tested with a NZ IBD patient who is a health researcher and their 
feedback and suggestions were incorporated into a revised survey.  The survey was subsequently sent to 
the UK and distributed through an IBD dietitian to 14 patient volunteers.  Feedback from the pre-testing 
phase was provided to the candidate via email and was used to make questions and response options 
clearer and highlighted electronic links that were not working.  The survey was finalised with 48 questions.  
Pre-test responses in Qualtrics were deleted before the finalised survey (Appendix One) was distributed 
in NZ. 
3.2.2 Dietitian survey pre-testing 
The draft electronic dietitian survey was sent to members of the Dietitians Crohn’s Colitis Australian 
Network and pre-tested with five members.  Feedback regarding usability and question topics was sent 
by email to the candidate.  The survey was modified in response to the feedback and the survey was 
finalised with 49 questions (Appendix Two). 
3.2.3 Gastroenterologist survey pre-testing 
The draft electronic GI survey was sent to a group of gastroenterology specialists working in Australia.  
Five pre-tested the survey and their emailed feedback was incorporated in the final survey, which had 28 




3.3 Survey dissemination 
3.3.1 Patient survey dissemination 
The electronic patient survey was distributed during March/April 2020 to over 2000 patients and/or 
families via social media and the Crohn’s and Colitis New Zealand (CCNZ) email list.  IBD specialist nurses 
and dietitians were encouraged to share the survey link with their patients.  The recruitment target was 
300 patients based on a previous NZ study using similar methods 143.  While the survey was open, NZ went 
into a strict lockdown for five weeks in response to the COVID-19 pandemic which may have affected 
response rates while people adjusted to this unusual situation.  For this reason, the survey was kept open 
for an extended period (seven weeks, rather than the five weeks originally planned).  A reminder was put 
on social media the week prior to the survey closing. 
3.3.2 Health professional surveys’ dissemination 
The dietitian survey was advertised via the Dietitians NZ (the professional association for dietitians) 
newsletter and Facebook page as well as in the newsletter of the Gastroenterology special interest group 
of Dietitians NZ.  In addition, the researcher made phone calls to the dietetic department of each District 
Health Board (DHB) to promote the survey directly.  The GI survey was advertised via the NZ Society of 
Gastroenterology newsletter and email network, with reminders sent directly to GIs in the research 
supervisors’ email networks.  The health professional surveys were open for completion for two months 
between July and September 2020. 
3.4 Data Analysis 
3.4.1 Qualitative data analysis  
A general inductive approach was chosen to analyse qualitative data collected.  Thomas describes this as 
a simple, straightforward approach to analyse qualitative data which can be easily used by those less 
familiar with specialised qualitative data analysis to produce reliable and valid findings 144.  This approach 
involves detailed readings of free text responses to allow dominant themes to emerge, that are 




Sciences 144.  To ensure this analysis was robust, the candidate and one supervisor independently analysed 
responses to questions with free text replies to confirm the dominant themes.  Selected verbatim patient 
quotes that represented key themes are included in the results and discussion sections.  
3.4.2 Quantitative data analysis 
All quantitative data collected was categorical and reported as numbers and percentage of total 
responses.  Contingency tables were created with categorical variables and results were analysed for 
statistical significance by either Chi-square or Fisher’s exact test as appropriate.  To determine whether 
any patient characteristics or other variables were associated with finding dietitian advice useful, or 
whether age was associated with waiting time to see a dietitian, the responses/ages were ranked from 1 
to 5 and Mann Whitney or Kruskal-Wallis non-parametric tests (as appropriate) were conducted.  A p-
value of less than 0.05 was regarded as statistically significant.  Statistical analysis of quantitative data was 
completed in GraphPad Prism software version 9.0.2 (GraphPad Software, LLC).   
3.4.3 Rural versus urban classification 
Researchers from the University of Waikato and the University of Otago collaborated to develop a system 
called the Geographic Classification for Health (GCH) (not yet published).  This system uses travel time to 
different sized population centres to create a map of NZ that classifies areas as Urban 1 or 2 and Rural 1, 
2 or 3.  For the purposes of our data analysis, postcode data supplied by patients was used to map their 
location and the GCH map was used to classify respondents as urban or rural.  Where a postcode straddled 
an urban/rural boundary, the data was excluded from this analysis.   
3.5 Ethical Approval 
The health professional surveys were deemed service evaluation and therefore did not require ethical 
approval.  The patient survey was deemed research and therefore required ethical approval.  The patient 
survey part of the thesis research proposal was submitted to the Health Research South Scientific Peer 




the quality of data collected.  This led to multiple changes to the proposal and the inclusion of additional 
questions in the patient survey.   
Consultation with Karen Keelan, Kaitohutohu Rangahau Māori, (University of Otago, Christchurch) 
ensured that the proposed research would benefit the hauora (health and wellbeing) of tangata whenua 
(Māori, the people of the land Aotearoa–New Zealand).  She acknowledged that current prevalence data 
indicates that only small numbers of Māori are affected by IBD 4 but that it is important to collect ethnicity 
data according to established methods to allow comparison of data between population groups.  She also 
recommended that patient participants are made aware that consent to collect data is for this study only 
and that results are appropriately disseminated to the study population.  The survey was designed to 
collect ethnicity data as per the Census 2013 question.  Any participants who did not consent to 
participating in the survey were exited immediately and thanked for their time in considering 
participation. 
An application for ethical approval was made to the University of Otago Human Ethics Committee 
(Health).  The committee initially gave conditional approval, requiring clarification on whether young 
people would be completing the survey or whether it would be done by parents.  The committee noted 
that at the end of the survey patients were urged to seek referral to a dietitian via their medical team if 
they wished to discuss IBD nutrition, but expressed concern that dietetic access was minimal.  The 
researcher responded to these issues, explaining that all DHBs and most PHOs in NZ provide publicly 
funded dietetic care to some degree although it is currently unknown to what level this is provided for 




Chapter Four Survey results 
4.1 Results format 
This chapter includes the results of the patient, GI and dietitian surveys.  The results are divided into 
the themes explored in the surveys, with relevant responses included under each section heading.  
The three surveys did not explore exactly the same topics so all groups (patients, dietitians, GIs) are 
not necessarily represented under every heading. 
4.2 Response numbers 
A total of 425 participants consented to completing the patient survey but, after being asked to 
identify their IBD type, only 407 were considered for analysis.  The dietitian survey generated 79 
responses and the GI survey had 40 responses, 36 from GIs and 4 from registrars.  Not all respondents 
to the surveys answered every question.   
4.2.1 Patient respondent demographics 
Patient demographics and disease characteristics are summarized in Tables 4.1 and 4.2.  More females 





Table 4.1 Patient demographics (n=407 responses) 
Gender n % 
Male 102 25.1 
Female 303 74.4 
Prefer not to answer 2 0.5 
Age   
Under 16 years 21 5.2 
16-24 years 53 13.0 
25-34 years 96 23.6 
35-44 years 80 19.7 
45-54 years 74 18.2 
55-64 years 54 13.3 
65-74 years 20 4.9 
75 or older 7 1.7 
Prefer not to answer  2 0.5 
Ethnicity    
New Zealand European 369 90.7 
Māori 22 5.4 
Samoan 0 0.0 
Cook Islands Māori 0 0.0 
Tongan 0 0.0 
Niuean 0 0.0 
Indian 2 0.5 
Other,  33 8.1 





Table 4.2 Patient disease characteristics 
IBD type n % 
Ulcerative Colitis 131 32.2 
Crohn's Disease 254 62.4 
IBD – unspecified 19 4.7 
Unsure 2 0.5 
Prefer not to answer 1 0.3 
Years since IBD diagnosis   
less than 1  31 7.6 
1-3  76 18.7 
3-5  58 14.3 
6-10  75 18.4 
over 10  164 40.3 
Prefer not to answer 3 0.7 
Surgery to treat IBD   
Yes 140 35.4 
No 266 65.4 
Prefer not to answer 1 0.2 
Abbreviations: IBD, inflammatory bowel disease 
The GCH was applied to 369 (91%) patients, of whom 309 (76%) were classified as living in an urban 
area and 60 (15%) in a rural area.  The remaining 38 patients either did not provide postcode data, 
recorded a postcode not currently allocated in NZ, or provided a postcode that straddled rural and 
urban zones so were unable to be classified using the GCH. 
4.2.2 Patient medications and supplements 
Most patients took at least one medication and 42 (10%) reported taking no medication (Table 4.3).  
The most common IBD medications were immunosuppressant (45.7%) followed by aminosalicylate 
medication (38.6%).  Approximately a third of patients (31%) received biologic treatment and 26.3% 
reported currently taking painkillers.  There were notable differences in medications between patients 




Table 4.3 Medications currently taken by patients 
Medications All  n=407 
n (%) 
Crohn’s disease  n=254 
n (%) 
Ulcerative Colitis  n=131 
n (%) 
Aminosalicylate  157 (38.6)  67 (26.3)  83 (63.4)  
Steroids  52 (12.8)  24 (9.4)  25 (19.1)  
Antibiotics 12 (3.0)  9 (3.5)  3 (2.3)  
Immunosuppressant  186 (45.7)  131 (51.6)  52 (39.7)  
Biologic  126 (31.0)  100 (39.3)  25 (19.1)  
Other  93 (22.9)  25 (9.8)  20 (15.3)  
Allopurinol 20 (4.9)  17 (6.7)  2 (1.5)  
Amitryptyline  17 (4.2)  12 (4.7)  5 (3.8)  
Painkillers  107 (26.3)  72 (28.3)  26 (19.8)  
Immunosuppressant and biologic 51 (12.5)  46 (18.1)  5 (3.8)  
Prefer not to answer 5 (1.2)  1 (0.4)  1 (0.8)  
None 42 (10.3) 28 (11) 12 (9.2)  
 
Many patients reported taking a wide variety of dietary and herbal supplements (Table 4.4).  
Supplemental vitamins or minerals were the most common supplement (44.2%) followed by 
probiotics and/or prebiotics (15.2%).  Fewer than a quarter (22.9%) reported not taking any dietary or 





Table 4.4 Supplements currently taken by patients 
Supplements All  n=407 
n (%) 
Crohn’s disease  n=254 
n (%) 
Ulcerative Colitis  n=131 
n (%) 
No supplements 93 (22.9)  51 (20.1)  35 (26.7)  
Probiotics / Prebiotics 62 (15.2)  31 (12.2)  28 (21.4)  
Vitamins / Minerals 180 (44.2)  123 (48.4)  46 (35.1)  
Herbal preparations or 
‘superfoods’ 
13 (3.2)  11 (4.3)  6 (4.6)  
Curcumin 14 (3.4)  7 (2.8)  5 (3.8)  
Fibre supplement 17 (4.2)  11 (4.3)  5 (3.8)  
Cannabis / CBD / Hemp 4 (1) 4 (1.6)  1 (0.8)  
Fish oil / Omega-3 5 (1.2)  2 (0.8)  3 (2.3)  
Ensure / Fortisip etc 6 (1.5)  4 (1.6)  2 (1.5)  
Prefer not to answer 39 (9.6)  24 (9.4)  12 (9.2)  
Abbreviations: CBD, cannabidiol 
4.3 Health professional characteristics 
4.3.1 Dietitians 
There were 79 responses to the dietitian survey.  The largest proportion of responding dietitians were 
aged between 25-44 years (56%), with 6% younger than 25 and 16% aged over 45 years.  Nearly half 
(47%) had gained dietitian registration over ten years ago but 19% had been registered for less than 
two years.  NZ European was the predominant ethnic group (84%) and no dietitians identified as 
Māori.  Every DHB area was represented by respondents. 
Most dietitians worked more than 30 hours per week (67%), a quarter worked 17-30 hours and 8% 
worked 0-16 hours per week.  Dietitians predominately worked in publicly funded healthcare settings 
and many worked in more than one setting (Table 4.5). Of those not currently working in a public 
hospital (14 respondents), eight had previously worked in this setting indicating 92% of respondent 
dietitians have experience in the public hospital setting.  In addition to the 18 currently working in a 





Table 4.5 Dietitian work settings* 
Setting Number working in this setting 
n = 79  
n (%) 
Public Hospital  65 (82.3)  
Private Hospital  1 (1.3) 
Private Practice  17 (21.5) 
Primary Health Organisation  4 (5.1) 
Māori Health Organisation  0 (0) 
Community Setting  16 (20.3) 
Public Health  0 (0) 
Research 2 (2.5) 
Food Industry  0 (0) 
Food Service Management  1 (1.3) 
Not currently practising 0 (0) 
Other 2 (2.5) 
*Dietitians could select more than one work setting. 
4.3.2 Gastroenterologists 
There were forty responses to the GI survey.  The largest group of respondents (38%) had graduated 
from medical school in the 1980s, 15% in the 1990s, 35% in the 2000s and 8% since 2010.  The majority 
(78%) were male.  Respondents represented most of the larger DHBs across the country, with the 
highest number of responses received from Canterbury DHB (13) followed by Auckland DHB (8).  Not 
all of the DHBs were represented, some of which may not have specialist gastroenterology services.  
No GIs reported working at Tairawhiti DHB, Lakes DHB, Taranaki DHB, Hawkes Bay DHB, Wairarapa 
DHB, Nelson-Marlborough DHB, West Coast DHB or South Canterbury DHB.  While three GIs saw both 
children and adults, thirty-three saw adults only and four saw children only.  All respondents currently 





4.4 Dietitians’ gastroenterology caseload  
The number of dietitians who answered questions pertaining to their caseload varied (65-78 
dietitians).  Most dietitians saw patients with gastrointestinal conditions at least weekly or several 
times per week (Figure 4.1).  This group of patients comprised 10-25% of the workload for over half of 
the dietitians. 
 
Figure 4.1 Frequency dietitians see patients with gastrointestinal conditions (n = 78) 
 
Most (87%) dietitians saw patients diagnosed with IBD, of whom 44% saw both IBD inpatients and 
outpatients, 18% saw only inpatients and 38% only outpatients.  Over 50% of dietitians saw IBD 
patients monthly or only a few times per year with much smaller numbers who saw this patient group 
more frequently (Figure 4.2).  The majority of dietitians (68%) saw only adults with IBD, while 15% saw 
only children and 17% saw both adults and children.  Larger numbers of dietitians (62%) responded 
that their patients come from mostly urban areas while 9% saw patients from mostly rural areas.  The 

















Figure 4.2 Frequency dietitians see patients with IBD (n=65) 
 
4.5 Views on relevance of nutrition and dietitians in IBD 
4.5.1 Do patients want access to dietitians? 
Patients were asked ‘Do you think it is useful for patients diagnosed with IBD to have access to a 
dietitian for nutrition advice?’.  Most patients (n=349 (86.2%)) responded ‘Yes’, 7 people (1.7%) 
responded ‘No’ and 49 (12.1%) responded ‘Maybe’.  The majority of patients (61.9%) thought it would 
be useful to receive dietary advice immediately upon diagnosis and 20.8% thought it would be useful 
to receive advice anytime.  With regards to the frequency of seeing a dietitian, 65.4% of patients would 
like to see a dietitian anytime that new issues related to nutrition come up, fewer than 7% of 
respondents wanted to see a dietitian only once or twice.  
4.5.2 Nutrition topics of interest to patients 
Patients had a wide range of topics that they would like to discuss with a dietitian.  A few (n=22) 
patients did not have any nutrition topics they wished to discuss or were unsure.  Patients could select 















responses as summarized in Table 4.6.  ‘Other’ text responses included suggestions such as diets to 
alter gut microbiota, information about vegan diets, foods that worsen IBD symptoms and how to 
increase dietary variety. 
Table 4.6 Nutrition topics of interest to patients 
Nutrition topics All 
n = 404 
n (%) 
Crohn’s disease 
n = 254 
n (%) 
Ulcerative Colitis 
n = 131 
n (%) 
Diets to reduce symptoms 304 (75.2)  188 (74.0)  100 (76.3)  
Healthy eating for IBD 290 (71.8)  184 (72.4)  93 (71.0)  
Impact of diet on IBD 286 (70.8)  175 (68.9)  94 (71.8)  
Diets to treat IBD 221 (54.7)  129 (50.8)  81 (61.8)  
Vitamins and minerals 209 (51.7)  132 (52.0)  66 (50.4)  
Diets to gain or lose weight 163 (39.6)  101 (39.8)  53 (40.5)  
Dietary fibre 140 (34.7)  94 (37.0)  35 (26.7)  
Other 19 (4.7)  14 (5.5)  2 (1.5)  
No / unsure 22 (5.4)  11 (4.3)  8 (6.1)  
Abbreviations: IBD, inflammatory bowel disease 
4.5.3 Gastroenterologists’ views on the relevance of nutrition to IBD 
Most GIs agreed that diet and nutrition are relevant to managing IBD, more so in Crohn’s disease than 
ulcerative colitis (Figure 4.3).  Nearly all (97%) GIs said that their patients ask about food, diet or 
nutrition in relation to IBD and 95% said that they provide nutrition advice to patients (Figure 4.4). 
The most common diet recommended was the low FODMAP diet followed by the low residue diet and 
CDED.  Other diets recommended included low dairy/gluten diets, the LOFFLEX (low fat, fibre limited 
exclusion) diet and a high protein diet.  Some (41%) GIs suggested various other sources of nutrition 






Figure 4.3 Gastroenterologists’ agreement with statement that diet and nutrition are relevant in 
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Figure 4.4 Nutrition interventions recommended by gastroenterologists to IBD patients 
Abbreviations: IBD, inflammatory bowel disease; EEN, exclusive enteral nutrition; PEN, partial enteral nutrition.    
Response options to the question were explained as follows: EEN = exclusive liquid formula diet; PEN = 
minimum of 50% of daily calories from liquid formula; Oral supplement drinks e.g. Ensure, Fortisip; 
Supplements = vitamin, mineral or electrolyte supplements; Specific diets e.g. low FODMAP 
(fermentable oligosaccharide, disaccharide, monosaccharide and polyol), low residue, LOFFLEX (low 
fat, fibre limited exclusion), CDED (Crohn’s disease exclusion), SCD (specific carbohydrate) etc 
 
There was wide variation in the proportion of patients that GIs usually referred to dietitians, from 
fewer than 5% to over 75%, see Figure 4.5.  All four paediatric GIs referred over 50% of their patients 































































Figure 4.6 Reasons that gastroenterologists refer IBD patients to a dietitian.   
Abbreviations: EEN, exclusive enteral nutrition; PEN, partial enteral nutrition; FGS, functional gastrointestinal symptoms 
 
GIs reported various barriers to referring more patients to a dietitian for IBD nutrition advice.  These 
included long waiting times, a desire not to overwhelm the dietetic service, inadequate dietetic service 
availability, limited access, lack of resourcing, no dedicated IBD dietitian, dietitian inexperience in IBD 
and insurance (presumably related to funding of private appointments).  A handful (10%) of GIs 
responded that there was no barrier to patients being reviewed by a dietitian in their area. 
4.6 IBD multidisciplinary teams 
According to dietitians surveyed, the majority (63%) of organisations did not have an IBD MDT, 13% 
did and a quarter of dietitians were unsure if their organisation had an IBD MDT.  Of the nine dietitians 
who worked in a health service with an IBD MDT, 5/9 of the MDTs included a dietitian, 3/9 did not 

































organisations’ IBD MDT included combinations of GI, registrar, colorectal surgeon, IBD nurse, 
pharmacist, psychologist and dietitian. 
Equal numbers of GIs stated that they were, or were not, part of a service with an IBD MDT (48% 
respectively) and two GIs were unsure.  For those services which had an MDT, GIs reported that the 
health professionals included in the team were varying combinations of GI, registrar, colorectal 
surgeon, IBD nurse, psychologist, radiologist, histopathologist and general surgeon.  GIs from five 
DHBs responded that their MDT included a dietitian: Northland DHB, Auckland DHB, Waitemata DHB, 
Midcentral DHB and Canterbury DHB. 
4.7 Patients who have seen a dietitian 
Half the patients surveyed (197/407) had not seen a dietitian for IBD nutrition advice.  Three patients 
were referred to a dietitian but did not attend the appointment, eight responded they were ineligible 
for a publicly funded appointment and 181 people (44.9%) had never been referred.  Half of the 
patients (210/407) had seen a dietitian for IBD nutrition advice; the majority were referred by their GI 
(55.2%) or self-referred (16.7%).  A large proportion (43.1%) saw a dietitian immediately or within 1-
3 months following their IBD diagnosis, but a significant number (39.8%) first saw a dietitian more 
than 1 year after diagnosis.  Of those who had seen a dietitian, 78 (37%) were seen during an overnight 
stay in hospital and 142 (67.3%) had seen a dietitian as an outpatient.  Most (59.5%) had seen a 
dietitian at a public hospital; 34.8% had seen a dietitian at a private hospital/clinic or private practice 
rooms. Most (71.9%) saw the dietitian in a dietitian-only appointment rather than in an MDT setting. 
4.7.1 Patient characteristics 
Patient characteristics were analysed to see which, if any, characteristics were associated with 
participants having seen a dietitian (Table 4.7).  A total of 52% of patients had seen a dietitian.  A 
significant association for participants who had seen a dietitian was observed for age, IBD sub-type, 
prior IBD surgery or treatment with biologic therapy.  Younger participants, those with Crohn’s 
disease, those currently on biologic therapy and those who had undergone surgery to treat IBD were 
more likely to have seen a dietitian for IBD advice.  Gender, ethnicity, years since IBD diagnosis and 
travel time were not associated with having seen a dietitian.  Younger patients also had a shorter 




fewer rural patients having seen a dietitian than those living in urban areas, this did not reach 
statistical significance (40.6% vs 53.3%, p=0.088). 
Table 4.7 Characteristics of patients who had seen a dietitian (n=210) 
 n % p-value 
Gender   0.729 
Male 54 54.0%  
Female 155 51.5%  
Age   <0.001* 
Under 16 years 17 85.0%  
16-24 years 39 75.0%  
25-34 years 47 49.5%  
35-44 years 37 46.3%  
45-54 years 30 40.5%  
55-64 years 25 47.2%  
65-74 years 10 50.0%  
75 or older 4 57.1%  
Ethnicity, more than 
one response possible 
218 responses  0.532 
NZ European 192 52.6%  
Māori 9 42.9%  
Other 17 45.9%  
IBD type   0.001* 
Ulcerative Colitis 53 40.5%  
Crohn's Disease 149 59.4%  
IBD - unspecified 7 38.9%  
Years since diagnosis   0.869 
less than 1 year 14 46.67%  
1-3 years 37 50.00%  
3-5 years 33 57.89%  




over 10 years 86 52.44%  
Travel time to see IBD 
dietitian 
  0.1576 
up to 30 minutes 144 57.1%  
0.5-1 hour 37 45.1%  
over 1 hour 16 57.1%  
Surgery to treat IBD   <0.001* 
Yes 91 65.9%  
No 119 45.3%  
Receiving biologic 
therapy to treat IBD 
  0.005* 
No biologic therapy 132 47.4%  
Biologic therapy 72 62.1%  
Biologic therapy and 
immunosuppressant 
33 66.0%  
Rural versus urban   0.088 
Rural 24 40.6%  
Urban 163 53.3%  
*p-value is statistically significant. Abbreviations: IBD, inflammatory bowel disease.  There were varied numbers of responses 
to different questions as respondents had the option of choosing ‘prefer not to answer’ to all questions. 
4.8 Malnutrition screening 
Nine GIs from four DHBs reported that their clinic routinely screens for malnutrition in IBD patients, 
two GIs were unsure.  The number of patients identified as malnourished or at high risk of malnutrition 
varied, with four GIs reporting rates of less than 10%, three GIs between 10-25% and two GIs reporting 
rates of 25-50%. 
4.9 Dietitian nutrition screening and assessment  
4.9.1 Nutrition assessment tools 
The dietitian survey indicated that nutrition assessment practice in IBD varies.  Standardised nutrition 




MNA (Mini Nutritional Assessment), MUST (Malnutrition Universal Screening Tool), MST (Malnutrition 
Screening Tool), SGA/PG-SGA (Subjective Global Assessment/Patient Guided Subjective Global 
Assessment) and the SaskIBD-NR tool (Saskatchewan IBD Nutrition Risk).  Other processes listed were 
ADIME (Assessment, Diagnosis, Intervention, Monitoring and Evaluation), Standard NCPT (Nutrition 
Care Process Terminology) - another way of describing ADIME - and the Starship Health IBD protocol.   
While these are not recognised standardised nutrition assessment tools, they are standardised 
processes for nutritional assessment.  
Many participants who said that they did not use standardised nutrition assessment tools also listed 
the ADIME/NCPT processes.  Other assessment methods included using BMI/growth charts, holistic 
assessment, general assessment, patient questioning, PCDAI (Paediatric Crohn’s Disease Activity 
Index) score, ABCDE (Anthropometric, Biochemical, Clinical, Diet, Emotional/social/stress) 
assessment, bowel records, DHB nutrition assessment sheet, food records and diet/appetite 
assessment. 
4.9.2 Anthropometry 
Almost all respondents used weight, height and BMI to assess anthropometry (81-85%), with only 
single responses of mid-arm circumference and hand grip strength.  Some dietitians used SGA.  A single 
dietitian responded that they use a non-diet approach so no numbers are recorded during assessment.  
Most dietitians (83%) assessed anthropometry at the initial assessment, with over half reassessing this 
at all follow-ups, although approximately one-third will only re-assess when they feel it is relevant. 
4.9.3 Biochemistry 
A quarter (28%) of dietitians stated that they always use biochemistry results in IBD patient 
assessment but a further 54% said they would use these results if they were available, which may 
depend on their work setting.  A single dietitian reported that they do not use biochemistry in 
assessment, two stated that they do not have access to biochemistry results and two responded that 
they are not sure which tests are relevant.   
Dietitians were asked which three biochemistry tests they consider the most relevant in nutritional 
assessment of IBD patients.  The five most common responses (in order from the highest number of 




electrolytes, vitamin B12/folate.  Other tests listed included erythrocyte sedimentation rate, liver 
function, renal function, fat soluble vitamins, vitamin D, albumin, pre-albumin, protein, calcium, 
magnesium, phosphate, zinc, coeliac markers and lymphocytes. 
4.9.4 Other clinical information 
Other clinical data that dietitians reported routinely collecting and assessing included concurrent 
medical conditions, family history, disease activity, current medications and supplements, previous 
treatments, treatment plan, surgical history, bowel habit or stoma output assessment, gastrointestinal 
symptoms, flare history, dietary habits, food sensitivities, medication allergies/reactions, relationship 
with food, general energy levels, physical activity levels, scan/investigation reports, dental health, 
functional abilities and quality of life. 
4.9.5 Dietary assessment 
All dietitians used diet recall and food or food and symptom diaries to assess dietary intake, sometimes 
in conjunction with other methods such as food frequency questionnaires.  This was done more often 
at the initial appointment than follow-up appointments.   
4.10 Diet therapies used by dietitians 
Dietitians reported using a range of nutrition interventions in Crohn’s disease and ulcerative colitis 
(Figure 4.7).  Nearly all dietitians (90%) reported ‘usually’ or ‘almost always’ providing written advice 





Figure 4.7 Nutrition interventions recommended in IBD by dietitians.  
Abbreviations: IBD, inflammatory bowel disease; EEN, exclusive enteral nutrition; PEN, partial enteral nutrition.    
Response options to the question were explained as follows: EEN = exclusive liquid formula diet; PEN = 
minimum of 50% of daily calories from liquid formula; Oral supplement drinks e.g. Ensure, Fortisip; 
Supplements = vitamin, mineral or electrolyte supplements; Specific diets e.g. low FODMAP 
(fermentable oligosaccharide, disaccharide, monosaccharide and polyol), low residue, LOFFLEX (low 
fat, fibre limited exclusion), CDED (Crohn’s disease exclusion), SCD (specific carbohydrate) etc 
 
4.11 Patient experience of dietetic service 
Patients who had seen a dietitian were asked about the type of advice they received.  The most 
frequent recommendation was to follow a particular diet, most commonly the low FODMAP diet, 
followed by the low residue diet.  There were also single recommendations of: the Crohn’s Disease 
Exclusion diet; a low-fat diet; the Omega diet; and an anti-inflammatory diet.  Results are summarized 

































Table 4.8 Patient recollection of advice provided by dietitian 
Advice All 
n = 210 
n (%) 
Crohn’s disease 
n = 148 
n (%) 
Ulcerative Colitis 
n = 53 
n (%) 
Advised to trial particular diet  
(e.g. low residue, low FODMAP etc) 
112 (53.3) 77 (52.0) 29 (54.7) 
General nutrition advice 109 (51.9) 79 (53.3) 27 (51.0) 
Prescribed oral nutrition supplements  
(e.g. Fortisip / Ensure etc) 
84 (40.0) 59 (39.9) 25 (47.2) 
Assistance with EEN 37 (17.6) 31 (20.9) 6 (11.3) 
Other 26 (12.4) 18 (12.2) 7 (13.2) 
Prescribed vitamin / mineral / electrolyte 
supplements 
20 (9.5) 12 (8.1) 8 (15.1) 
Recommended PEN (at least 2 meals / day) 18 (8.6) 12 (8.1) 6 (11.3) 
Recommended to trial natural product 10 (4.8) 6 (4.1) 2 (3.8) 
Abbreviations: FODMAP, fermentable oligosaccharide, disaccharide, monosaccharide and polyol; EEN, exclusive enteral 
nutrition; PEN, partial enteral nutrition.    
4.11.1 Was the dietitian advice useful? 
Two-thirds (66.3%) of respondents found the dietitian advice at least moderately useful (moderately 
useful, very useful or extremely useful) and 17.8% reported that the advice was not at all useful. Initial 
analyses suggested that receiving written advice and the type of dietitian clinic were possibly 
associated with perceived usefulness of dietitian advice.  As these associations could have been 
affected by the large percentage of participants grouped together as ‘useful’, they were further 
analysed by breaking them down into ranked responses. Statistical tests confirmed that there were 
significant associations between the perceived usefulness of dietitian advice and receiving written 
advice (p <0.0001) or the type of dietitian clinic where the patient was seen (p =0.0001).  Those 
participants who had seen a dietitian in a private clinic or had received written advice were more likely 




4.11.2 Adherence to dietitian advice 
Almost all respondents (90.5%) followed or partially followed the dietitian/s’ advice and provided 
various reasons for doing so. 
Table 4.9 Reasons for following dietitian advice 
Why did you follow the advice?  n % 
I trust health professionals 69 23.5 
It seemed as if it would be helpful 94 32.0 
The dietitian seemed well informed 77 26.2 
I had already tried a lot of other diet 
strategies 
19 6.5 
Other 32 10.9 
Prefer not to answer 3 1.0 
 
Some of the other reasons given included:  
‘I was desperate to get healthy’;  
‘To try and find a solution other than surgery or medication’;  
‘It was already what I was doing ie low fibre and healthy, no new information’;  
‘We demanded our son be given Elemental not Fortisip and eventually she gave 
in. We followed her recommended amount, which was 10 units a day’;  
‘The dietitian was well informed, had the latest study information about IBD diet 
related issues and is also a Crohns patient herself so really understood the 
information and implications’. 
A small group (5.3%) of respondents said that they did not follow the advice for reasons such as:  
the participant was ‘not willing to try different foods, I suspect because it has 




‘can’t remember what I was told as only a few days post-surgery’;  
‘it’s bullshit’;  
‘dietician didn’t fully understand IBD and admitted to this’;  
‘eating a high fibre diet is not helpful for my Crohn’s disease’;  
‘They prescribed foods I had told them I knew I didn’t tolerate. They didn’t listen 
to me’.   
When participants were asked ‘If you had important questions to ask the dietitian/s, did you get 
answers that you could understand?’, 64.9% answered yes, although 13.3% of people weren’t sure.  
In response to the question ‘Did you have confidence and trust in the dietitian?’ 59.2% chose yes, 
23.2% chose no and 16.6% chose ‘I’m not sure’. 
4.12 Nutrition information from other sources 
A third of patients (130 people, 32.5%) had received nutrition advice from another health professional, 
most commonly their GI, GP or IBD nurse.  Other professionals providing nutrition advice included 
practice nurse, nutritionist, naturopath, paediatrician, general physician, immunologist, counsellor, 
cannabis practitioner, integrated health professional, osteopath, surgeon and herbalist.  Most 
commonly this was general nutrition advice or advice to trial a particular diet such as the low residue 
or low FODMAP diet.  Also mentioned were ketogenic, low carbohydrate - high fat, vegan, low fat - 
low lactose, sugar free, specific carbohydrate, gluten and dairy free, Mediterranean and exclusion 
diets.  Several varieties of herbal, probiotic and vitamin/mineral supplements were also 
recommended.  Three quarters of patients (76%) found the advice at least moderately useful. 
Over half of the patients (56.4%) had also sought nutrition advice from another source, predominantly 
the internet.  IBD support organisations, IBD patients (either in person or via online forums), books 
and friends were other sources of nutrition advice.  The majority (72%) of respondents found the 
advice at least moderately useful but one comment from a patient was:  
‘Everyone has an opinion about what will assist with IBD. No doubt one will be 
right for me however I stopped researching when they ruled out eating cooked 




4.13 Self-funded appointments and health insurance 
Patients who had paid to see a dietitian (n=78) did so for various reasons.  Free text comments 
included that some patients were not aware of any publicly funded dietetic service or were ineligible 
for publicly funded care.  Others responded that they believed they would receive more 
specialised/personalised care from the privately funded service or wished to avoid a waiting list or 
because their health insurance covered the cost.  Some people paid to see a particular dietitian who 
was recommended to them. 
Over 40% (173) of patient survey respondents said that they had health insurance although 33 of these 
said that their insurance plan did not cover the cost of an appointment with a registered dietitian.  A 
further 83 respondents were unsure.  A smaller number (57 people) responded that their health 
insurance plan did cover appointments with a dietitian but mostly under limited circumstances e.g. 
referred by a specialist, or only after a related medical procedure.  A relatively small number (34) had 
accessed health insurance to pay for an IBD-related consultation with a dietitian. 
4.14 Access to publicly funded dietetic care 
Of the fifty-seven dietitians working in organisations which provide publicly funded care, 35% reported 
access criteria which affect IBD patient access to the service with the remaining 65% of services 
accepting all local IBD referrals.  Patients are most frequently referred to dietetic services by GIs, 
followed by GPs and IBD nurses.  Referral acceptance criteria reported included newly diagnosed IBD, 
malnutrition/weight loss, pre-operative nutrition support or referral for EEN therapy. 
4.14.1 Gastroenterologists’ experience of dietitian service access 
Most (89%) GIs responded that they have access to an inpatient dietitian service, 82% have a publicly 
funded outpatient service and 50% have access to privately funded outpatient dietitian services.  All 
twelve DHBs represented in the survey had access to publicly funded dietitian services and while six 
GIs responded that they can only access inpatient services and one solely a privately funded outpatient 
service, no-one responded that they do not have access to any dietitian services at all.  Half (49%) 
responded that the dietetic service is a specialist gastroenterology service rather than a general 




GIs in some areas reported that referral criteria exist which affect publicly funded access to dietetic 
services for IBD patients.  One-fifth (22%) of participants responded that this is the case in their area, 
46% were unsure and 32% responded that referral criteria do not affect dietitian access.  Over half 
(57%) of GIs responded that in their opinion there were not enough dietitians in their area to meet 
the nutrition advice needs of current numbers of IBD patients, 24% were unsure and 19% believed 
that there were enough dietitians in their area.  
 
Figure 4.8 Do gastroenterologists believe patients benefit from dietitian review? 
 
Overall GIs agreed that, in their experience, most IBD patients experience a positive benefit from 
seeing a dietitian (see Figure 4.8).  This is despite finding that only 14% of GIs believe that NZ dietitians 
are well trained in the nutritional management of IBD.  The majority (78%) believe that the training 































4.15 Dietetic service capacity 
Dietitians were asked whether they could see higher numbers of IBD patients with their current FTE 
/workforce resourcing (see Figure 4.9 and Figure 4.10).  They suggested a range of possible service 
changes to allow more IBD patients to be seen, including declining other referrals, increased funding 
for more dietitian FTE, more use of tele-health/virtual appointments, giving IBD patients higher 
priority when triaging, allowing longer waiting lists or reducing dietitian non-contact time.  Less than 
one-third of dietitians currently felt adequately resourced to provide appropriate follow-up to IBD 
patients.  Many commented that there were minimal publicly funded services in their area and that 
patients often had to wait a long time for a follow-up appointment with potential for their nutritional 
status to deteriorate in the meantime.  In some services patients were discharged following nutrition 
intervention for their current nutrition diagnosis so would not be seen again unless re-referred for a 
new nutritional problem.  Some dietitians commented that they felt adequately resourced for current 
referral numbers but were concerned that increased referrals could not be accommodated.  Others 
mentioned adequate inpatient services but inadequate outpatient follow-up.  Some dietitians felt 
inadequately resourced in terms of limited specialist IBD education or knowledge.  While most services 
will accept referrals for IBD patients with functional gastrointestinal symptoms, 12% of dietitians 





Figure 4.9 Capacity of dietitians to see increased IBD patient referrals 
 






















































4.15.1 Waiting times for appointments 
Patients were asked how long after diagnosis they had seen a dietitian (Figures 4.11 - 4.17).  A 
statistically significant difference was found between patients’ age and length of time between 
diagnosis and dietitian review.  Younger patients were seen more quickly by a dietitian than older 
patients (p=0.0001).   
Dietitians working in paediatrics stated that paediatric patients are commonly seen within a month of 
referral.  In the adult service, dietitians responded that appointment waiting times depended on 
nutrition status at time of referral, or it could vary depending on waiting list at the time 
 
Figure 4.11 Timeframe to see dietitian for 
patients aged under 16 years 
 
 
Figure 4.12 Timeframe to see dietitian for 


























Figure 4.13 Timeframe to see dietitian for 
patients aged 25-34years 
 
Figure 4.14 Timeframe to see dietitian for 




Figure 4.15 Timeframe to see dietitian for 
patients aged 35-44years 
 
Figure 4.16 Timeframe to see dietitian for 







































Figure 4.17 Timeframe to see dietitian for 








4.16 Dietetic service development 
Dietitians were generally confident or very confident that patients experience a positive benefit from the 
dietetic service (Figures 4.18 and 4.19).  A small percentage (12%) of dietitians strongly agreed that they 
are up to date with the nutritional management of IBD with a further 49% somewhat agreeing that they 










































Figure 4.19 Dietitian level of confidence that they are up to date with the nutritional management of IBD.   
Abbreviation: IBD, inflammatory bowel disease 
 
Common themes regarding how dietetic services could be improved indicated a desire by dietitians to 
improve IBD nutrition care; the strongest theme was a desire for a more multidisciplinary approach, with 
increased collaboration between members of the IBD healthcare team.  Dietitians also frequently 
highlighted a need to have further education and training in nutrition therapy for IBD to achieve best 
practice but stated that they would require time and funding allocated to education to enable this to 
occur.  In addition to increased MDT collaboration and education, dietitians frequently stated that 
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4.17 Australasian guidelines 
Most (88%) dietitians would value Australasian guidelines and protocols for the nutritional assessment of 
inflammatory bowel disease, with a further 8% ‘maybe’ valuing this.  Two dietitians (4%) thought this was 
not necessary.  Even higher numbers (92%) would value Australasian guidelines on nutritional therapies 
in IBD, with no dietitian responding that this was not necessary.  The reasons for these responses were 
similar for both questions, with some common themes: generalist dietitians seeing IBD patients were 
unsure if their practice was current; guidelines allow non-specialist dietitians to benefit from specialist 
dietitian knowledge; local (Australasian) guidelines can be useful tools to provide evidence of benefits of 
dietetic service/recommendations to patients/medical staff/DHBs; guidelines may reduce variation in 
services and improve equity and consistency of care for patients; and Australasian guidelines would be 
relevant to our population, health system and food supply.  Two-thirds (65%) of GIs surveyed thought that 
patients would benefit from Australasian guidelines for the nutritional assessment and management of 
IBD. 
4.18 Patient and gastroenterologist suggestions for dietetic services 
4.18.1 Patients 
Patients had many suggestions for how current nutrition or dietetic services could be improved. The most 
common theme referred to, with 45 comments, was the need for dietitians to have specific knowledge of 
IBD and to provide more specific evidence-based IBD nutrition advice.  Respondents also frequently 
commented that all patients diagnosed with IBD should routinely be referred to a dietitian and there 
should be greater access to publicly funded dietitians: 
‘Have specialist IBD nutritionists available’ 
‘Dietician services are in my opinion essential to maintaining good health and taking 
control over IBD. Our experience with initial dietician was invaluable’ 





‘Paradoxical Crohns introduces the need for advice on constipation and toileting 
techniques such as squatting’ 
‘Nutrition is a large part of IBD so there should be advice readily available, I had to 
push to see a dietitian and I found that she wasn’t very informed about IBD and what 
would be useful, just kept saying if you find your stomach flares after eating a type of 
food then don’t eat it. Felt very isolated and ignored’ 
‘Adult patients should be offered EEN and told that it takes 12 weeks to heal 
inflammation so no food means your body can heal. Advice about diet as alternative 
to drugs. PEN And anti-inflammatory foods or medical diet like CDED rather than just 
giving drugs’ 
‘I found the current service so prescriptive (heres a sheet on healthy eating, low 
residue food list) - not keen to discuss research or supplements.’ 
‘Dietitians should be telling me about the latest information.’ 
‘I would like to see a routine referral for patients diagnosed with IBD’ 
‘Could improve it if more funding available so ALL IBD sufferers got offered a free 
dietitian review every 1-2 yrs’ 
‘Nutritional/ dietitian consultations should be part of the process once diagnosis has 
been made’ 
‘I think all people with IBD should see an Dietitian annually alongside blood tests to 
confirm their nutrition needs are being met as best they can be.’ 
‘All newly diagnosed patients should be referred to a dietician, regardless of whether 
they are treated privately or publicly’ 
‘It would be great if all IBD patients are routinely offered dietary advice, and do not 





A common theme was the desire for a greater degree of follow-up from dietitians, so that patients are 
not seen only once or twice and then discharged; respondents wished to have dietitians available on an 
ongoing basis in the same way that IBD nurses were available to answer questions: 
‘I would like more regular catchups with a dietitian. I’ve had Crohn’s for 27 years now 
so would like to see a dietitian to discuss new ideas and nutritional advice.’ 
 ‘I think that Dieticians need to be available to IBD patients all the time as it makes a 
big difference to your health to have the support of a good professional to guide you 
through what can at times be a really difficult thing to do.’ 
‘Yes each year a review with a dietitian would be good. And it should be offered by gp 
and specialist instead of needing to ask for it’ 
 ‘Better follow up and ongoing diet support’  
‘Would be a good idea to have a dietician on call’ 
‘I think MDT specialist appointments with the DT is a great idea. I can contact my 
gastro nurse via email with questions that don't necessarily require an in person 
appointment, the ability to do this with a DT would be really helpful. From my 
experience with Crohn's not a lot of emphasis has been placed on diet for managing 
symptoms and preventing potential nutrient deficiencies. Rather dietary intervention 
has usually been used as a reactive tool during flare-ups e.g. low residue diet, 
enteral/parental nutrition. It would be nice to see more focus on diet for general well 
being with chrons for those patients that are interested.’ 
Respondents wished to see a greater emphasis on lifestyle aspects of IBD treatment and expressed 
concern that medical staff frequently said that diet is not important and dietary therapies do not make a 




‘I think that every patient should be able to access one for free. I was told that diet 
has no impact on my IBD at all but would have liked the opportunity to talk to a 
specialist in that field’ 
‘I'd like to see specialist teams referring patients more regularly. At one point the 
foods I could eat were so limited that I probably should have seen a dietician, but 
despite asking if this was warranted, I was not referred.’ 
 ‘When diagnosed let them know about diet options right away because I was told my 
IBD wasn’t related to diet and on Low FODMAP my symptoms were the most normal 
they’ve been in a while.’ 
‘GIs have always said that diet does not help IBD which seems ridiculous’ 
‘I think GIs and nurses should also be educated around diet; I was told diet did not 
matter one bit!’ 
‘Get rid of the attitude that its not related to diet.’ 
‘We should actually get eating advice I have even asked and never been referred’ 
‘I think a much more integrated approach, with diet, natural herbs, supplements and 
medicine would be much better. The functional medicine approach, much more 
holistic’ 
Some respondents had never received dietitian referral or had to request it themselves; they would like 
to have been told that dietetic services were available or that dietary strategies might be relevant and 
wished that they had been referred to a dietitian: 
‘As i haven't been offered dietitian services i think being offered that would be a step 
in the right direction’ 




‘I have been desperate to see one for years but never had an appointment although 
ive asked many times’ 
‘Current services could be improved by actually referring patients to dietitians - but 
also ensuring that the dietitians themselves have the relevant knowledge for IBD and 
related diet options, latest studies etc’ 
‘Any advice would be handy’ 
‘yes, we should be offered these services, i personally requested to be referred to a 
dietitian and got nowhere.’ 
Some patients wished to receive pamphlets, written IBD dietary guidelines, linked into group support or 
directed towards reliable information online or have online/phone support available:  
‘Yes leaflets or books given on diagnosis’ 
‘I would like to see a group type meeting held once a month for those with any IBD 
disorder where we can have a group chat about how IBD affects our lives and share 
what we do to help ourselves, with a dietician/nutritionist sitting in on the 
conversation as back up.’ 
‘A phone support line would be beneficial’ 
‘leaflets, flyers, online info and opportunity to ask questions as they arise’ 
‘As a first step each newly diagnosed patient should receive a comprehensive 
handout of what is and isn’t recommended during a flare, as most people have no 
idea, unless they’ve conducted their own research.‘ 
‘Perhaps an on line Dietitian linked to Crohn's and Colitis National website’ 
‘Regular seminars would be good’ 




Some respondents took the opportunity to highlight how much they valued the dietetic service they had 
accessed: 
‘Our experience with initial dietician was invaluable’ 
‘Hospital admissions should mean you see a dietician at the same time. Too many 
times I've battled the catering team in a hospital to explain what i can and can't eat, 
see the hospital dietician and its sorted immediately.’ 
‘Just want to say my Dietician has been super helpful.’ 
‘I have been very privileged to have a top class dietician and gastro consultant. We 
work together as a team.’ 
4.18.2 Gastroenterologists 
GIs were given the opportunity to make any final comments about IBD dietetic services if they wished.  
These are printed below: 
‘I cannot overstate how much I value the input of my dietetic colleagues. Their 
expertise is essential in providing appropriate care to children with IBD.’ 
‘The dietetic departments in many hospitals I have worked in are highly professional 
and very effective but often unable to cope with demands on their time.’ 
‘Neglected area with pretty good evidence, which people have forgot or never been 
exposed to. FODMAPs often the only thing they know. Shame.’ 
‘EEN and PEN are evidence based, steroid free treatment that can help IBD patients. 
These options are not available because of major restrictions on dietician resource. 
Patients with other indications are able to access dietician support, therefore this 
creates inequity for IBD patients who so frequently can’t access this support from 
highly valued dietician colleagues.’
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Chapter Five Discussion 
IBDs are chronic diseases of the gastrointestinal tract.  Therefore, diet therapy plays an important role 
in IBD treatment and management, both for patients who are newly diagnosed with IBD and for those 
with longstanding disease.  Local studies have confirmed the increasing prevalence of IBD in NZ.  IBD 
incidence rates in Canterbury increased by 1.6-fold over a ten-year period, to one of the highest rates 
ever reported in the world 4.  Recent years have seen increased research into the role of diet in IBD.  
Some NZ-based research investigated the use of EEN 60, 119 but there has been little other research into 
dietetic care in IBD in NZ.  Data has been lacking on the capacity of NZ dietitians working with IBD 
patients and NZ patients’ access to, and experience of dietetic services.  Our project aimed to gather 
this data and provide recommendations for future IBD dietetic service provision and improvement.  
Our research collected data through the dissemination of three electronic surveys to IBD patients, 
dietitians and GIs.   
Based on international research we expected that many patients would not have seen a dietitian for 
IBD nutrition advice 123, 124, 126, 127.  Some of the anticipated barriers to dietitian access were inadequate 
numbers of publicly funded dietitians, cost of private practice dietitians, and lack of emphasis by 
medical staff on the role of diet in IBD.  Our findings showed that half the patient respondents had 
seen a dietitian, slightly more than anticipated based on the literature.  In various surveys carried out 
in the UK, USA and Australia, the proportion of adult patients who had seen a dietitian ranged from 
12 – 47% 36, 123, 126, 127.  The higher proportion seen in our results might be explained by the inclusion 
of paediatric patients in our survey, in contrast to most other research which was limited to adult 
patients.  We found that younger patients were more likely to have seen a dietitian and that paediatric 
GIs refer a greater proportion of their patients to dietetic services than adult GIs do.  In a Polish study 
of parents of children with IBD, over 60% stated that they were easily able to access dietitian advice 
137.  International IBD management guidelines recommend nutrition assessment of all patients and 
state that adults and children with IBD should have access to dietetic support and nutrition therapies 
1-3.  There is clearly a gap between guideline recommendations and actual practice.     
Patients in NZ were clearly in support of access to dietitians with almost all responding positively that 
patients should have access to a dietitian for nutrition advice.  Nearly every respondent had topics 
that they wished to discuss with a dietitian, with many wishing to have the option to see a dietitian 
anytime that new issues related to nutrition come up.  These high numbers are consistent with 
overseas research 36, 123, 126.  American patients who were surveyed considered nutrition a very 
 
 
Page 65 of 179 
important part of their IBD care 36.  Prince et al 123 interviewed a group of adult IBD patients and over 
three-quarters of those who had not previously seen a dietitian would like to do so; similar results to 
another survey where 85% of adult patients would like an appointment with a dietitian 126.   
GIs’ views corresponded with patients, with most agreeing that diet and nutrition are relevant to 
managing IBD, although more so in Crohn’s disease than ulcerative colitis.  Almost all doctors said that 
they provide nutrition advice to patients.  Despite this, there is wide variation in the proportion of IBD 
patients that doctors refer to dietitians, with some referring fewer than 5% and others over 75% of 
patients.  Of the patient respondents, 45% reported that they had never been referred to a dietitian.  
As patients and GIs agree regarding the importance of diet in IBD, it would seem that there are barriers 
to dietitian access which cause many patients never to have seen a dietitian rather than there being a 
general disinterest in diet.    
A combination of factors contributed to low patient dietitian access to dietitians.  Of the fifty-seven 
dietitians working in organisations which provide publicly funded care, approximately two-thirds 
accepted all local IBD referrals with the remaining services having various criteria which restricted IBD 
patient access to dietetic services.  Referral acceptance criteria included: newly diagnosed IBD; 
identified malnutrition and/or weight loss; pre-operative nutrition support; referral for EEN therapy.  
The restrictive criteria potentially leave gaps in access for patients living in these service areas who 
wish to discuss symptom management, nutrition optimisation or minimisation of nutrition risk or 
dietary strategies to assist in flare treatment and management.  Audits of IBD care in the United 
Kingdom and Australia have also found inadequate levels of dietetic support.  In a 2014 audit of IBD 
services against the UK standards 2, 7% of services stated that they did not have a dietitian experienced 
in the dietary management of IBD available to refer patients to 145.  An audit of Australian IBD hospital 
resources found that only 29/61 general hospitals had an IBD dietitian on-site 35.  Neither of the audits 
mentioned the existence of referral criteria governing access to dietetic services. 
Previous research has not investigated whether patients who have seen a dietitian have different 
characteristics compared with those who have not.  Our research found that patients who were 
younger, had Crohn’s disease, on biologic therapy or had undergone surgery to manage IBD were 
more likely to have seen a dietitian.  Younger patients also saw a dietitian more quickly after diagnosis 
than older patients. 
Reasons for the differences between those who have, or have not, seen a dietitian are likely to be 
varied.  Younger patients whose nutrition is compromised can experience detrimental impacts on their 
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growth and long-term bone health; paediatric management guidelines emphasise the importance of 
dietetic care to an even greater degree than adult guidelines 52.  We found that NZ GIs believe nutrition 
is more relevant in Crohn’s disease.  There may be a perception that Crohn’s disease patients are at 
higher nutrition risk than colitis patients due to the potential for greater lengths of diseased 
gastrointestinal tract or prior surgery affecting key regions of nutrient absorption.  However, this 
assumption is not supported by research, which indicates similar malnutrition rates in both UC and 
Crohn’s disease 22, 23.  Crohn’s disease patients might also be referred for dietitian review in higher 
numbers as IBD management guidelines highlight nutrition strategies in Crohn’s disease management 
while there are no evidence-based nutrition strategies widely recommended in ulcerative colitis 1, 21, 
52.  Patients on biologic therapy or those who have required surgery are likely to have more severe 
disease, requiring greater interaction with health services, so may be more likely to receive 
multidisciplinary input 138.  Equally, as medication escalates patients may be more likely to seek out 
other therapies that can assist in disease management.  This was reflected in some of the comments 
received from patients about their reasons for following dietitian advice, e.g.  
‘(I wanted) to try and find a solution other than surgery or medication’;  
‘I was determined to avoid the major immunosuppressant drugs as I was told that 
would be for the rest of my life.  I felt that was Dealing with the symptoms and 
not the cause’. 
Of those patients who had seen a dietitian, over a third had been seen at a private facility, presumably 
at their cost (or partially funded by health insurance).  Many of these patients stated that they were 
not aware of any publicly funded dietetic service or were ineligible for publicly funded care.  Restrictive 
access criteria which result in patients needing to seek privately-funded services raise obvious equity 
concerns, whereby those who cannot afford to pay to see a private practitioner cannot access the 
same level of healthcare and may not achieve the same health outcomes.  This contradicts the 
philosophy behind the development of NZ’s universal, tax-funded national health service, whereby all 
New Zealanders should have equal access to the same standard of treatment 146.  The reality is that 
inequities of health outcomes for some population groups, including lower socio-economic groups, 
are a persistent problem in NZ 146.   
It is also known that people living in rural areas have greater difficulty accessing specialist health 
services than those who live in urban areas, which can negatively affect health outcomes 147, 148.  Our 
survey received a greater number of responses for those living in urban versus rural areas, which is 
not surprising, as over 80% of New Zealanders live in urban areas.  The survey responses indicated 
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that there was a trend towards greater numbers of patients from urban areas having seen a dietitian 
than those who live in rural areas.  This did not reach statistical significance but the research was not 
adequately powered with enough rural participants to make a true comparison.  The majority of 
dietitians stated that they see patients from mostly urban areas with fewer than 10% drawing most 
of their patients from rural areas.  With increased use of tele-health, particularly since the start of the 
COVID-19 pandemic, barriers that rural patients have experienced accessing health services should be 
able to be dismantled.  Dietetic care provided via tele-health has been shown to be effective and 
improves service access for rural patients 149.  A survey of IBD patients found that they were willing to 
have dietetic services delivered via telehealth and that patients’ main concern was access to a 
specialist IBD dietitian 125.  Wider implementation of telehealth services could reduce the need for 
patients to seek out private practice-based dietitians and improve equity of care. 
It is important that when patients access dietetic services, these meet patient needs and expectations.  
International research has found that patients are frequently dissatisfied with the quality of nutrition 
advice or information provided 131, 133. NZ patients were asked whether the dietitian advice received 
was useful.  Most found the dietitian advice at least moderately useful but concerningly, a number of 
patients reported that the advice was not at all useful.  Similarly, while most patients who received 
advice from a different health professional or another source such as the internet or IBD support 
organisations also found this useful, in each case a proportion of people did not.  Patients shed some 
light on their dissatisfaction in free-text comments, e.g.   
‘dietician didn’t fully understand IBD and admitted to this’;  
‘They didn’t listen to me’;  
‘The first dietitian that I saw really to be fair had no clue but the second one was 
very good’;  
‘I found the current service so prescriptive (heres a sheet on healthy eating, low 
residue food list) - not keen to discuss research or supplements.’ 
It is clear from these comments that dietitians lacking specialist knowledge of IBD is a source of 
frustration and disappointment for patients.  Dietitians also acknowledged this as an issue, with over 
one third not confident that they were up to date with the nutritional management of IBD and over 
half having gastroenterology as only a small part of their workload.  While over 79% of dietitians saw 
patients with gastrointestinal conditions at least once a fortnight, IBD patients appear to be a small 
part of the gastroenterology caseload with over 50% of dietitians seeing patients with IBD monthly or 
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a few times per year.  This may be due to greater recognition of the role for dietitians in the 
management of other gastrointestinal conditions such as coeliac disease or irritable bowel syndrome. 
Many dietitians identified the need for additional education and upskilling in IBD nutrition, for 
example via webinars, workshops or courses led by specialist dietitians, with regular updates as new 
research is published and incorporated into practice.  While online and in-person training programmes 
are available for dietitians wishing to update their knowledge in IBD management, a lack of time and 
funding for continuing education in publicly funded services were noted as barriers to this occurring.  
The most recent Allied Health Multi-Employer Collective Agreement, which covers 17 of the 20 NZ 
DHBs, has no set minimum provision of time or funding for continuing education 150.  Most GIs 
considered NZ dietitians’ level of training in the nutritional management of IBD to be variable, echoing 
the views of patients and dietitians.   
Dietitians are not alone in identifying the need for additional post-registration training in IBD 
management.  A national audit of IBD specialist nurses’ roles and services in NZ was recently carried 
out with responses from 15 out of 25 specialist nurses 151.  Well over half the nurses employed in 
specialist roles had not completed any formal educational programmes or modules relating to IBD and 
the need for specialist training was identified.  Similar to findings from our dietitian survey, most 
nurses also had clinical responsibilities outside IBD.  Concurrently working in areas outside IBD means 
that clinicians have less opportunity to develop specialist knowledge in IBD and professional 
development time and funding may have to be split with other clinical areas. 
It was pleasing to note the benefit IBD patients experience when they have access to dietitians with 
an appropriate level of expertise, which was reflected in the positive comments of some patients and 
GIs, e.g. 
‘Our experience with initial dietician was invaluable’; 
‘The dietitian was well informed, had the latest study information about IBD diet 
related issues and is also a Crohns patient herself so really understood the 
information and implications’; 
‘I have been very privileged to have a top class dietician and gastro consultant. 
We work together as a team’;  
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‘I cannot overstate how much I value the input of my dietetic colleagues. Their 
expertise is essential in providing appropriate care to children with IBD.’  
Data we collected showed that there was a significant difference in patients’ experience based on the 
clinic setting, with higher numbers of patients who had seen a dietitian in a private clinic finding the 
advice useful.  Interestingly, despite this difference in patient experience, nearly 60% of dietitians had 
worked in both public and private settings suggesting that it is not necessarily a difference between 
the practitioners themselves, but perhaps a function of the environment.  For example, in private 
clinics there may be a shorter waiting time to be seen, longer appointment times or differences in 
follow-up practices when compared with publicly funded services, all of which may improve the 
patient experience.  This is supported by comments from some patients about why they chose to see 
a dietitian in a private clinic (shorter wait times) and from dietitians working in publicly funded services 
who stated that there is not enough workforce resourcing available for adequate follow-up of 
patients. 
Our research findings were also clear that patients who received written nutrition information from a 
dietitian found the advice more useful than those who did not.  Fewer than half the dietitians surveyed 
responded that they always provide written advice to patients.  Providing written advice could be 
incorporated as standard practice for health practitioners, ensuring that the information is available 
for patients’ future reference.  It is important, however, that written material is of an appropriate 
standard and produced by independent (non-commercial) sources as some research has indicated a 
lack of quality, objective, IBD-specific resources 131.  Some dietitians expressed a desire to have 
standardised regional or national resources to use with patients, which would help to provide a level 
of quality control and consistency between services.  This would assist dietitians for whom IBD is not 
a large part of their practice and in turn, could improve patient satisfaction with dietetic services. 
We were interested to discover what diet advice patients have received.  Over half the patients were 
recommended by a dietitian to follow a particular diet, most commonly the low FODMAP diet, 
followed by the low residue diet.  This advice correlates well with patients’ interest in diets to reduce 
IBD symptoms, although there could be concerns about the frequent use of the low residue diet, which 
does not have a strong evidence base for widespread use to prevent gastrointestinal symptoms or 
improve disease outcomes 152.  Both diets are designed to be used for a short period of time only.  Of 
the patients who had received advice from other health professionals, just under half recalled being 
told to follow a particular diet such as the low residue or low FODMAP diet.  Various other exclusion 
diets were also mentioned, including some with no evidence of benefit in IBD, indicating that other 
 
 
Page 70 of 179 
health professionals are recommending a wider range of these types of diets than dietitians.  Exclusion 
diets bring with them concerns regarding potential dietary inadequacy which can contribute to 
increased malnutrition risk in this relatively vulnerable patient group 23.  Exclusion diets need to be 
closely monitored to regularly assess the risks versus benefits of dietary exclusions and to ensure that 
macro- and micronutrients continue to be provided in appropriate amounts to support long-term 
health.  The potential detrimental effects of dietary exclusions on patient stress levels related to eating 
and food-related quality of life should also not be ignored 133. 
With significant rates of malnutrition in IBD, regular malnutrition screening and assessment of patients 
is recommended 1-3.  While work has been done to develop malnutrition screening tools specific to 
IBD 24, in our research doctors from just four DHBs reported that their clinic routinely screens for 
malnutrition in IBD patients.  Interestingly, there was wide variation in the number of patients 
identified as malnourished or at high risk of malnutrition through the screening process, from less 
than 10% up to 25-50%.  Unfortunately, no information was collected on which screening tool or 
process was used to identify malnutrition risk, so we are unable to state what was responsible for the 
differences in rates.  It could be that a range of approaches were used or it could be that different 
practitioners perceive nutrition risk differently.  It is known that standard malnutrition screening tools, 
which often emphasise BMI and weight changes, underestimate nutrition risk in IBD populations 24.  
Like the rest of the population, a growing number of IBD patients are classified as overweight or obese 
153.   The differences in identification of malnutrition are likely to have contributed to the discrepancies 
in rates of referrals to dietitians referred to above, although other factors such as dietitian availability 
and dietetic service access criteria may influence this too. 
Nutrition assessment processes used by dietitians also varied, as there is no universally agreed 
nutrition assessment tool specific for IBD 26, 31.  Dietitians reported using a number of different 
approaches and validated tools when carrying out nutritional assessment of IBD patients.  These 
results show that there is not a uniform approach across NZ to malnutrition screening and nutritional 
assessment of patients, raising concerns regarding equity of care. 
Various organisations have written IBD standards of care stating the requirement for patients to be 
cared for by a multidisciplinary team, including a specialist dietitian; for patients to have a full 
nutritional assessment on diagnosis and have ongoing access to all forms of appropriate nutritional 
therapy; for patients to have nutritional assessment whenever admitted to hospital and prior to any 
surgery; and for outpatient reviews to include a review of nutritional status 2, 3.  However, it is clear 
that if all patients were to have dietitian access, this would have a large impact on dietetic services.  
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The increasing incidence of IBD in NZ would compound this issue 4.  GIs reported various barriers that 
currently prevent more patients from seeing a dietitian, mostly relating to a lack of dietetic services 
or no dietitian specialised in IBD.  Nearly 80% of dietitians responded that they would require changes 
to their services to enable them to see more IBD patients.  Other than increased resourcing, some of 
the changes suggested included re-prioritising other patient referrals, which would clearly impact 
other patient groups, or decreasing non-contact time which could contribute to excessive workload 
and decreased quality of service.  Over half the GIs were of the opinion that there are not enough 
dietitians in their region to meet the nutrition advice needs of IBD patients.  These views were 
exemplified in the following comments:     
‘The dietetic departments in many hospitals I havd worked in are highly 
professional and very effective but often unable to cope with demands on their 
time’;  
‘EEN and PEN are evidence based, steroid free treatment that can help IBD 
patients. These options are not available because of major restrictions on 
dietician resource. Patients with other indications are able to access dietician 
support, therefore this creates inequity for IBD patients who so frequently can’t 
access this support from highly valued dietician colleagues’ 
Patients also commented on a lack of available dietetic services: 
‘I have been desperate to see one for years but never had an appointment 
although ive asked many times’; 
‘More dietiticians please’; 
‘Too hard to access publicly funded’  
A dominant theme from the dietitian survey was that greater MDT collaboration could improve 
dietetic services for IBD patients.  Doctors from five out of twenty NZ DHBs reported that their DHB 
had an IBD MDT which included a dietitian while some other DHBs have an IBD MDT but without a 
dietitian.  In a NZ national audit of outpatient IBD care carried out in 3 stages between 2015-2019, 
three DHBs were regarded as having the full complement of health professionals (including dietitians) 
required for a comprehensive IBD MDT 117.  Of the 63% of DHBs which had regular MDT meetings, 
dietitians were included in only 20% of these 117.  International IBD management guidelines are clear 
that gold-standard care involves a multidisciplinary healthcare team, which includes dietitians 2, 21, 29.  
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The reality is that many dietitians who see IBD patients work quite separately from their 
gastroenterology colleagues (medical specialists and nurses) as dietitians work in a wide variety of 
settings.  Dietitians believe their services would be improved if they had stronger relationships with 
others in the IBD healthcare team.  Some noted the benefit of joint MDT clinics to foster collaboration 
and to allow nutrition interventions to be implemented in a timely manner without needing a separate 
referral to the dietetic service, which often causes a delay in commencing nutrition therapy.  
This research had both strengths and limitations.  Sending an electronic survey link was a cost-effective 
method of collecting data from across NZ as the survey links were easy to distribute via existing 
networks.  This data collection method had a low participant burden as it allowed participants to 
complete the survey at a time which was convenient to them and also ensured that the information 
collected was anonymous.  The ethnicity data suggested that patient respondents were representative 
of the ethnic breakdown of NZ IBD patients.  Very few respondents self-identified as Māori (5.4%), 
with the majority identifying as NZ European.  This is in keeping with regional studies carried out in NZ 
whereby very few Māori patients were identified with IBD 14.  Similarly, disease breakdown data 
reflected prior regional studies.  Patients were more likely to have Crohn’s disease (62%), with 32.2% 
diagnosed with ulcerative colitis and 4.7% with IBD-unspecified, reflecting the results of the 
Canterbury study whereby incidence rates were twice as high for Crohn’s disease as ulcerative colitis 
4.  Respondents were spread across the age groups, with the largest cohort between 25-34 years of 
age, corresponding with the most common age of IBD diagnosis 7. 
A limitation was that this research method was unlikely to provide a fully representative sample of 
patients, as it required participants to have internet access and be confident navigating a reasonably 
long survey.  This discriminated against those less likely to use the internet or who lacked confidence 
using unfamiliar websites e.g. older people and socio-economically deprived groups.  Distribution of 
the patient survey link was done by IBD healthcare professionals, including dietitians, and CCNZ, which 
can be expected to miss those less engaged in health and support services.  The voluntary nature of 
the survey was more likely to generate responses from those most interested in nutrition, or those 
who felt strongly about their experiences relating to dietetic services (good or bad).  Patients with a 
greater interest in nutrition were also more likely to have seen a dietitian, raising the possibility that 
the true proportion of NZ IBD patients who have seen a dietitian may be lower than observed.   
The majority of the participants in our patient survey were female, despite epidemiological studies in 
NZ indicating similar numbers of males and females with IBD 4.  While it is unknown exactly why there 
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was a difference in gender response, it is known that females generally engage more readily in 
healthcare 154.     
While dietitians and GIs are all required to use the internet for their work, eliminating the potential 
response bias of poor internet access, it remains true that those who are most interested in the topic 
of dietetic care in IBD are more likely to complete the survey.  This could skew some results, for 
example, there may be some GIs who did not respond to the survey who believe that nutrition is not 
at all relevant in IBD management, which corresponds with some patient reports of their interactions 
with some medical staff.  As the dietitian survey was promoted directly to members of the Dietitians 
NZ Gastroenterology Special Interest Group (Dietitians NZ Gastro SIG), responses are more likely to 
have come from dietitians with an interest in gastroenterology rather than all dietitians who see IBD 
patients.  Therefore, the proportion of all NZ dietitians who are confident in IBD nutrition may be 
lower than results suggested. 
5.1 Implications for practice 
This research has highlighted several issues with implications for the care of IBD patients in NZ.  
Patients clearly do not have adequate or equitable access to dietetic services.  To improve access the 
development of, or endorsement of existing, IBD standards of care would enable current dietetic 
services to be benchmarked and audited around the country.  This would highlight areas where 
patients lack access to dietitians so that business cases can be put forward to advocate for more 
equitable care.  If NZ was to adopt the same recommended standards of care as the UK and Australia 
2, 3 (0.5FTE specialist gastroenterology dietitian per 250 000 head of population, in addition to 
paediatric gastroenterology dietitians), this would provide twenty half-time specialist dietitian 
positions across the country for adults, plus additional paediatric dietitians.   
To improve consistency of nutrition screening and assessment a working party, led by a suitable group 
such as the Dietitians NZ Gastro SIG, could choose an appropriate malnutrition screening tool to be 
recommended for IBD clinics around the country and endorse a nutrition assessment tool and/or 
process to be used by dietitians working with IBD patients.  Options to collaborate with the equivalent 
Australian dietitian group should also be explored, to facilitate a consistent approach with Australia, 
which would make these recommendations more robust.   
Even if further specialist dietitian positions are created, some IBD patients are still likely to be seen by 
generalist dietitians working in other roles.  In order to assist dietitians who wish to upskill in the 
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nutritional management of IBD, the Dietitians NZ Gastro SIG could gather a suite of literature and 
training opportunities that are recommended for dietitians working in this area.  Existing written 
resources could be endorsed, or where required new resources developed, to ensure that high quality 
information is consistently provided to patients whomever they may see.  An ideal outcome would be 
for a national IBD dietitian position to be created, based with an organisation such as CCNZ, to 
coordinate and lead the process of professional development for dietitians and other health 
professionals, as well as ensuring up to date nutrition information and resources are widely available 
to dietitians and the public.  Those working in specialist dietitian roles would be able to support and 
mentor dietitians who see lower numbers of IBD patients, helping to improve the standard of care 
provided. 
The changes required to facilitate increased dietitian inclusion in IBD multidisciplinary teams may 
involve different approaches, depending on individual settings.  Relationship building, increased 
resourcing, re-prioritisation of other activities or timetable changes (to enable a part-time dietitian to 
attend) could be required, for example.  The population spread in NZ can create difficulties in providing 
the full breadth of specialist healthcare services in all locations, however, virtual tools could be used 
to assist in this.  Electronic case reviews, virtual MDT meetings, joint telehealth appointments are all 
options that could be explored for those settings where in-person meetings are not realistic or 
feasible.  Greater use of telehealth could allow particularly complex patients to be seen by specialist 
dietitians, no matter where the patient lives. 
5.2 Future research 
While this research has provided new and useful information on dietetic services in IBD in NZ, and 
characteristics of patients who have seen a dietitian compared with those who have not, some gaps 
in knowledge remain.  It is unknown exactly what the differences are in dietetic services between the 
DHBs or in differing locations within DHBs.  Greater numbers of rural-living patients could be surveyed 
to allow further examination of any urban versus rural differences in IBD care.  Future research could 
also assess variations in malnutrition screening practices and any barriers to implementing routine 
malnutrition screening of IBD patients.  An audit of written resources currently provided by dietitians 
to patients would be useful to assess these and determine if new resources need to be developed.  
5.3 Conclusion 
The project has achieved its key aims. 
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1. To investigate IBD patients’ experiences of dietetic services, including who has had access to 
services and whether services met their needs and expectations. 
Our research shows that there is inequitable and inadequate access to publicly funded dietetic 
services for IBD patients in NZ, with many patients struggling to access dietitians and substantial 
numbers of patients paying for dietitian appointments.  Patients wish to have ongoing dietitian access 
to address nutrition needs that may vary across their life and disease course.  For patients to gain the 
most benefit from dietetic care, patients report that it is important that dietitians have specialist IBD 
knowledge and provide quality written information to support their advice. 
To improve equity of access, the development of IBD dietetic standards of care would enable current 
dietetic services to be benchmarked and audited around the country.  A national IBD dietitian position 
would help to lift the profile of dietetics in IBD and lead the development of more consistent care, 
with advocacy for additional resourcing where required.  Greater use of telehealth could assist in 
improving dietitian access and follow-up. 
2. To evaluate the capacity of the NZ gastroenterology dietitian workforce, including their 
current workload related to IBD, ability to manage potentially increasing numbers of patients 
with IBD and their self-perceived knowledge and skill level in the nutritional management of 
IBD. 
Dietitians acknowledge the need for additional upskilling in the nutritional management of IBD.  
Dietetic services require additional resourcing to meet current and future needs of IBD patients.  The 
Dietitians NZ Gastro SIG could lead a process to ensure up to date IBD nutrition education and 
resources are widely available to dietitians. 
3. To assess GIs’ experience of NZ IBD dietetic services. 
GIs have had mixed experiences of IBD dietetic services, with some reporting very positive experiences 
and adequate dietitian resourcing in their areas.  Others found services were inadequately resourced 
and dietitian training in IBD management was variable.   
Advocacy needs to occur to ensure equitable dietetic services are provided nationally. In addition to 
further IBD-specific training for dietitians, relationship building and increased resourcing will assist to 
improve dietitian involvement in IBD MDTs. 
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4. To investigate whether differences exist in access to dietitians for patients living in rural areas 
versus urban areas. 
It appears that there may be less access to dietitians for IBD patients in rural areas.  Further research 
is needed to confirm whether this apparent trend is true. 
Stronger links between dietitians and IBD multidisciplinary teams may help to address observed 
variations in malnutrition screening, patient experience and referral rates to dietetic services.  
Increased use of telehealth may help improve access to services.  An enhanced MDT approach will 
ensure that nutrition therapy is collaborative, well supported by the medical team and implemented 
in a timely manner.  While some dietetic services already provide care at this level, further work is 
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Appendix One  
Patient survey 
 
Start of Block: Consent, Intro and demographics 
Q1     
Dietetic care in the treatment and management of inflammatory bowel disease in New Zealand 
  Thank you for showing an interest in this University of Otago project. Please read this information 
carefully. This research aims to explore patients' experiences of dietetic care (care provided by a 
registered dietitian) in the treatment and management of inflammatory bowel disease (IBD) in New 
Zealand (NZ). We are seeking opinions from patients with IBD and from parents/guardians of children 
diagnosed with IBD.    The information collected in this research will help inform recommendations to 
improve dietetic care, and thereby improve health outcomes and quality of life for patients with IBD. If 
you decide to participate, you will be asked to complete an anonymous online survey. Many of the 
questions are multi-choice. We estimate the survey will take approximately 10 minutes to complete. If 
you do not wish to answer a question, you can choose  this option.  
  The survey is open to people living in NZ diagnosed with IBD and parents/guardians of children diagnosed 
with IBD. We would ask that anyone under the age of 16 who wishes to complete the survey does this 
with their parent/guardian.  You will not be disadvantaged in any way if you choose not to participate. All 
survey data collected will be anonymous and any email addresses collected will not be linked to survey 
responses. Data will be held for at least 10 years in a password protected file on a University of Otago 
server. It will only be available to the researcher and her supervisors.  After you have completed the survey 
you will be taken to a separate page where, if you wish to, you can enter your email address to go in the 
draw for one of three $50 grocery vouchers.  This draw is to say thank-you for taking part in the research.  
Your email address will not be linked to your responses.  If you have any questions about this survey, 
please contact: Nicky McCarthy, Masters in Health Sciences student, email: 
mccni838@student.otago.ac.nz or,  
Dr Catherine Wall, Department of Medicine, Christchurch, email: catherine.wall@otago.ac.nz    This study 
has been approved by the University of Otago Human Ethics Committee (Health).  If you have any concerns 
about the ethical conduct of the research you may contact the Committee through the Human Ethics 
 
 
Page 87 of 179 
Committee Administrator (phone 03 479 8256 or email gary.witte@otago.ac.nz).  Any issues you raise will 
be treated in confidence and investigated and you will be informed of the outcome. 
o Yes I consent to participate in the survey  
o No, I do not consent to participating in the survey  
 
Skip To: End of Survey If   Dietetic care in the treatment and management of inflammatory bowel disease in New 
Zealand   Th... != Yes I consent to participate in the survey 
 
 
Q2 Thank you for taking part in our survey.  We would like to know your thoughts about nutrition in 




Q3 What is your gender? (if you are completing the survey on behalf of a child with IBD, please record 
their gender) 
o Male  
o Female  
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Q4 How old are you? (if you are completing the survey on behalf of a child with IBD, please record their 
age) 
o Under 16 years  
o 16 - 24 years  
o 25 - 34 years  
o 35 - 44 years  
o 45 - 54 years  
o 55 - 64 years  
o 65 - 74 years  
o 75 or older  
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Q5 Which ethnic group do you (your child) belong to? (Choose the answers that apply) 
▢ New Zealand European  
▢ Māori  
▢ Samoan  
▢ Cook Islands Māori  
▢ Tongan  
▢ Niuean  
▢ Indian  
▢ Other, please tell us which ethnicity/ethnicities 
________________________________________________ 
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Q6 What is the postal code at your home address?  (If you are unsure, you can check your postcode 
here by typing in your address) 
o Postcode ________________________________________________ 
o Prefer not to answer  
 
End of Block: Consent, Intro and demographics 
 
Start of Block: IBD info 
 
Q7 What type of IBD do you have? (or your child if you are answering on their behalf) 
o Ulcerative Colitis  
o Crohn's Disease  
o IBD - unspecified  
o Unsure  
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Q8 When were you (or your child) diagnosed with IBD? 
o less than 1 year ago  
o 1-3 years ago  
o 3-5 years ago  
o 6-10 years ago  
o over 10 years ago  
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Q9 What medication/s are you (your child) currently taking to treat IBD? Select all that apply 
▢ Aminosalicylate (e.g. Pentasa, Asacol, Asamax, Dipentum, Salazopyrine)  
▢ Steroids (e.g. Prednisone, Budesonide, Methylprednisolone, Colifoam)  
▢ Antibiotics  
▢ Immunosuppressant (e.g. azathioprine - Imuran, Azamun; methotrexate - Methoblastin, 
Trexate)  
▢ Biologic (e.g. Humira, Remicade/Infliximab)  
▢ Allopurinol  
▢ Amitryptyline (e.g. Amirol)  
▢ Painkillers (e.g. paracetamol, codeine, tramadol etc)  
▢ Other - please describe ________________________________________________ 
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Q10 Do you (your child) take any supplements? 
o Probiotics or prebiotics  
o Vitamins/minerals  
o Herbal preparations or 'superfoods'  
o Curcumin  
o Fibre supplement  
o Other - please describe ________________________________________________ 
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Q11 Have you (your child) previously had surgery to treat IBD? 
o Yes  
o No  
o Prefer not to answer  
 
Q12 How long is it since you (your child) last had an IBD flare? 
o less than 3 months  
o 3-6 months  
o 6 months to one year  
o 1-3 years  
o 3-5 years  
o over 5 years  
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End of Block: IBD info 
 
Start of Block: Dietitian access 
 
Q13 Do you think it is useful for patients diagnosed with IBD to have access to a dietitian for nutrition 
advice? ( A dietitian is a registered health professional who provides evidence-based food and nutrition 
advice to support optimal health) 
o Yes  
o Maybe  
o No  
o Prefer not to answer  
 
Skip To: Q16 If Do you think it is useful for patients diagnosed with IBD to have access to a dietitian for nutri... = No 
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Q14 After receiving an IBD diagnosis, when do you think it would be useful to receive nutrition information 
from a dietitian? Select all that apply 
▢ Immediately after diagnosis  
▢ 1-3 months after diagnosis  
▢ 3-6 months after diagnosis  
▢ 6-12 months after diagnosis  
▢ Anytime  
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Q15 How often would you like to see a dietitian for IBD nutrition advice for you or your child? 
o Just once  
o Twice  
o 3-4 times  
o 5+ times  
o Whenever new issues related to nutrition come up  
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Q16 Are there any nutrition topics that you would like to discuss with a dietitian?  Select as many as apply 
to you or explain in the 'Other' box 
▢ Healthy eating for IBD  
▢ Impact of diet on IBD  
▢ Dietary fibre  
▢ Vitamins and minerals  
▢ Diets to reduce symptoms  
▢ Diets to treat IBD  
▢ Diets to gain or lose weight  
▢ Unsure  
▢ No  
▢ Other ________________________________________________ 
▢ Prefer not to answer  
 
 




Q17 Have you ever seen a dietitian for IBD nutrition advice? 
o No - have never been referred  
o No - was not eligible for publicly funded dietitian service  
o No - was recommended but I did not attend the appointment  
o Yes  
o Prefer not to answer  
 
Skip To: Q18 If Have you ever seen a dietitian for IBD nutrition advice? = Yes 
Skip To: End of Block If Have you ever seen a dietitian for IBD nutrition advice? = No - have never been referred 
Skip To: End of Block If Have you ever seen a dietitian for IBD nutrition advice? = No - was not eligible for publicly 
funded dietitian service 
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Q18 Who referred you to see the dietitian? 
▢ Gastroenterologist  
▢ GP  
▢ IBD nurse  
▢ Practice nurse  
▢ Self-referred  
▢ Unsure  
▢ Other  
▢ Prefer not to answer  
 
 
Display This Question: 
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Q19 Why did you not attend the dietitian appointment? 
________________________________________________________________ 
 
Skip To: End of Block If Condition: Why did you not attend the ... Is Displayed. Skip To: End of Block. 
 
Page Break  
 
Q20 How long after diagnosis with IBD did you see a dietitian for the first time? 
o Immediately  
o 1-3 months  
o 3-6 months  
o 6-12 months  
o over a year  
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Q21 Have you seen a dietitian during an overnight stay in hospital? 
o Yes  
o No  
o Never stayed in hospital  
o I'm not sure  
o Prefer not to answer  
 
Q22 Have you seen a dietitian as an outpatient? 
o Yes  
o No  
o I'm not sure  
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Q23  
If you had important questions to ask the dietitian/s, did you get answers that you could understand? 
o Yes  
o No  
o I'm not sure  
o Prefer not to answer  
 
Q24 Did you have confidence and trust in the dietitian? 
o Yes  
o No  
o I'm not sure  
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Q25 Where have you seen a dietitian for an IBD related appointment?  Select all that apply 
▢ Public Hospital  
▢ Private Hospital/Private Gastroenterology Clinic  
▢ Dietitian private practice rooms  
▢ General practice medical centre  
▢ Other ________________________________________________ 
▢ Prefer not to answer  
 
Q26 If you have paid to see a dietitian (rather than accessing a publicly funded dietitian appointment), 
why did you choose to do this? 
o Reason ________________________________________________ 
o Have not paid to see a dietitian  
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Q27 Did you see the dietitian as part of a multi-disciplinary IBD clinic or in a separate appointment? 
o Multi-disciplinary IBD clinic  
o Separate dietitian only appointment  
o Unsure  
o Prefer not to answer  
 
 
Page Break  
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Q28 What type of advice were you given by the dietitian/dietitians?  Select all that apply 
▢ General nutrition advice  
▢ Advised to trial a particular type of diet e.g. low residue, low FODMAP, exclusion diet etc 
(Please write which diet you were advised to trial) 
________________________________________________ 
▢ Assistance with exclusive enteral (liquid) nutrition ie no solid food for several weeks  
▢ Recommended to trial partial enteral (liquid) nutrition, replacing at least 2 meals per 
day  
▢ Prescribed supplement drinks e.g. Fortisip, Ensure  
▢ Prescribed vitamin/mineral/electrolyte supplements  
▢ Recommended to trial natural product - please describe 
________________________________________________ 
▢ Other - please describe ________________________________________________ 
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Q29 Was the advice you were given by the dietitian/s useful? 
o Extremely useful  
o Very useful  
o Moderately useful  
o Slightly useful  
o Not at all useful  
o Prefer not to answer  
 
Q30 Did you receive written advice from the dietitian/s? 
o Yes  
o No  
o Can't remember  
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Q31 Did you follow the advice given by the dietitian/s? 
o Yes  
o No  
o Partially  
o Can't remember  
o Prefer not to answer  
 
Skip To: Q33 If Did you follow the advice given by the dietitian/s? = Yes 
Skip To: Q33 If Did you follow the advice given by the dietitian/s? = Partially 
 
 
Q32 If you didn't follow the advice, can you explain why not? 
________________________________________________________________ 
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Q33 Why did you follow the advice? 
▢ I trust health professionals  
▢ It seemed as if it would be helpful  
▢ The dietitian seemed well informed  
▢ I had already tried a lot of other diet strategies  
▢ Other - please describe ________________________________________________ 
▢ Prefer not to answer  
 
End of Block: Dietitian access 
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Q34 How long would you need to travel to see a dietitian about your IBD? 
o up to 30 minutes  
o between 30 minutes and 1 hour  
o between 1 - 2 hours  
o over 2 hours  
o I don't know  
o Prefer not to answer  
 
Q35 Do you have a health insurance plan? 
o Yes  
o No  
o Prefer not to answer  
 
Skip To: End of Block If Do you have a health insurance plan? = No 
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Q36 Does your health insurance plan cover appointment/s with a NZ registered dietitian? 
o Yes  
o Yes, under certain circumstance e.g. following a procedure / referred by a specialist  
o Unsure  
o No  
o Prefer not to answer  
 
Skip To: End of Block If Does your health insurance plan cover appointment/s with a NZ registered dietitian? = No 
 
Q37 Have you accessed health insurance to pay for an IBD related consultation with a dietitian?  
o Yes  
o No  
o Prefer not to answer  
 
End of Block: Health insurance and travel 
 
Start of Block: Other advice 
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Q38 Have you received IBD nutrition advice from another health professional (not a dietitian)? 
o Yes  
o No  
o Prefer not to answer  
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Q39 Which health professional provided this advice to you?  Select all that apply 
▢ Gastroenterologist  
▢ GP  
▢ IBD nurse  
▢ Practice nurse  
▢ Nutritionist  
▢ Naturopath  
▢ Other ________________________________________________ 
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Q40 What advice were you given by the health professional? Select all that apply 
▢ General nutrition advice  
▢ Advised to trial a particular type of diet e.g. low residue, low FODMAP, exclusion diet etc 
(please write which diet or diets you were advised to trial) 
________________________________________________ 
▢ Assistance with exclusive enteral (liquid) nutrition ie no solid food for several weeks  
▢ Recommended to trial partial enteral (liquid) nutrition, replacing at least 2 meals per 
day  
▢ Prescribed supplement drinks e.g. Fortisip, Ensure  
▢ Prescribed vitamin/mineral/electrolyte supplements  
▢ Recommended to trial natural product - please describe 
________________________________________________ 
▢ Other - please describe ________________________________________________ 
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Q41 Was the advice you received useful? 
o Extremely useful  
o Very useful  
o Moderately useful  
o Slightly useful  
o Not at all useful  
o Prefer not to answer  
 
Page Break  
Q42 Have you sought IBD nutrition information from another source?  
o Yes  
o No  
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Skip To: Q46 If Have you sought IBD nutrition information from another source?  = No 
Skip To: Q46 If Have you sought IBD nutrition information from another source?  = Prefer not to answer 
 
Q43 Where did you look for this information? Select all that apply 
▢ Official IBD support organisation  
▢ IBD patient online forum / social media group  
▢ Internet  
▢ Book  
▢ Other IBD patients  
▢ Other - please describe ________________________________________________ 
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Q44 What information did you find?  Select all that apply 
▢ General nutrition advice  
▢ Information on particular types of diet e.g. low residue, low FODMAP, exclusion diet etc 
(please write which diets were recommended) 
________________________________________________ 
▢ Information on exclusive enteral (liquid) nutrition ie no solid food for several weeks  
▢ Information on partial enteral (liquid) nutrition, replacing at least 2 meals per day  
▢ Recommendations about vitamin/mineral/electrolyte supplements - please describe 
________________________________________________ 
▢ Recommended to trial natural product - please describe 
________________________________________________ 
▢ Other - please describe ________________________________________________ 
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Q45 Was the information that you found useful? 
o Extremely useful  
o Very useful  
o Moderately useful  
o Slightly useful  
o Not at all useful  
o Prefer not to answer  
 
Q46  
Do you think that there are any other nutrition or dietitian services that should be offered to IBD patients, 




If taking part in this survey has raised any concerns for you, or if you would like to see a dietitian, please 
contact your GP or Gastroenterologist.  
 
 
A summary of the findings from this research survey will be available through Crohn's and Colitis NZ, 
advertised via their newsletter and Facebook page. 
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Thank you for your time in helping us with this research. 
 
End of Block: Other advice 
 
Start of Block: Voucher link 
 
Q48 If you would like to go in the draw for a grocery voucher to thank you for your time, please click on 
the link below.  This will take you to a separate website to enter your email address so that your contact 
details are separate from your survey responses. 
  
 Click here to enter your email address 
 





Dietitian survey  
 
Start of Block: Intro and demographics 
Q1     
Dietetic care in the treatment and management of inflammatory bowel disease in New Zealand 
 Thank you for showing an interest in this project.  This research aims to explore dietetic care in 
inflammatory bowel disease (IBD) in NZ from the perspective of patients, dietitians and 
gastroenterologists. To date, no research has looked at the current level of dietetic service for patients 
with IBD in NZ.  The aim of the information collected in this research is to inform recommendations that 
can improve dietetic care, and thereby improve health outcomes and quality of life for patients with 
inflammatory bowel disease. 
This is an anonymous online survey.  Many of the questions are multi-choice. We estimate the survey will 
take approximately 12-15 minutes to complete.  If you are in a service/practice where more than one 
dietitian sees patients, it would be greatly appreciated if all interested dietitians could complete the 
survey.  If you wish to, after the survey is completed, you will be taken to a separate link which will allow 
you to enter your email address to go in the draw for free registration at the DNZ Gastro SIG study day in 
2020 (or 2021 if 2020 event is cancelled) to say thank-you for taking part in the research. Your email 
address will not be linked to your responses. 
If you have any questions, please contact: Nicky McCarthy NZRD, candidate for Master's in Health 







Q2 What age group are you in?  
o 18 - 24 years  
o 25-34 years  
o 35 - 44 years  
o 45 - 54 years  
o 55 - 64 years  
o 65+ years  
o Prefer not to answer  
 
Q3 How many years since you gained registration as a dietitian? 
o <2 years  
o 3-5 years  
o 5-10 years  





Q4 Which ethnic group do you belong to? (Choose the answers that apply to you) 
▢ New Zealand European  
▢ Māori  
▢ Samoan  
▢ Cook Islands Māori  
▢ Tongan  
▢ Niuean  
▢ Indian  
▢ Other, please tell us which ethnicity/ethnicities 
________________________________________________ 
 






Q6 Would you classify your patients as coming from mostly urban or mostly rural areas? 
o Mostly urban  
o Mostly rural  
o About even urban and rural patients  
 
End of Block: Intro and demographics 
 
Start of Block: Work setting 
Q7 How many hours do you work per week? 
o 0 - 16 hours  
o 17 - 30 hours  





Q8 Which settings do you work in?  Select all that apply 
▢ Public Hospital  
▢ Private Hospital  
▢ Private Practice  
▢ Primary Health Organisation  
▢ Māori Health Organisation  
▢ Community Setting  
▢ Public Health  
▢ Research  
▢ Food Industry  
▢ Food Service Management  
▢ Not currently practising  





Q9 Which settings have you previously worked in?  Select all that apply 
▢ Public Hospital  
▢ Private Hospital  
▢ Private Practice  
▢ Primary Health Organisation  
▢ Māori Health Organisation  
▢ Community Setting  
▢ Public Health  
▢ Research  
▢ Food Industry  
▢ Food Service Management  
▢ Other ________________________________________________ 
 
End of Block: Work setting 
 





Q10 How frequently do you see patients with gastrointestinal conditions in your practice (on average)? 
o Several times per week  
o Weekly  
o Fortnightly  
o Monthly  
o A few times a year  
o Never  
 
Q11 What proportion of your work is this, approximately? 
o Very little  
o 10-25%  
o 25-50%  
o 50-75%  





Q12 Do you see patients diagnosed with Inflammatory Bowel Disease (IBD)? 
o Yes  
o No  
 
Skip To: End of Block If Do you see patients diagnosed with Inflammatory Bowel Disease (IBD)? = No 
 
 
Q13 Do you see IBD patients as inpatients/ outpatients/ both? 
o Inpatients  
o Outpatients  
o Both  
 
Q14 Do you have an IBD multidisciplinary team at your organisation/practice? 




contribute to the development of a patient care plan, or where more than one health profession meets 
with the patient in the same clinic? 
o Yes  
o No  
o Unsure  
 
Display This Question: 
If Do you have an IBD multidisciplinary team at your organisation/practice? i.e. a team which meets... = Yes 
 
Q15 Are you part of the IBD multidisciplinary team?  
 
o Yes  
o No  
o Unsure  
 
Display This Question: 





Q16 Which health professions are part of your IBD multidisciplinary team?  Choose all that apply 
▢ Gastroenterologist  
▢ Registrar  
▢ Colorectal surgeon  
▢ Radiologist  
▢ Histopathologist  
▢ IBD nurse  
▢ Pharmacist  
▢ Psychologist  
▢ Physiotherapist  
▢ Dietitian  





Q17 If you provide publicly funded care, do you have referral criteria that IBD patients must meet to be 
seen in your service? e.g. newly diagnosed, specific age range, identified malnutrition etc 
o No, will accept all local IBD referrals  
o N/A - I work only in privately funded care  
o Yes, please describe these ________________________________________________ 
 
 
Q18 Do you see adults or children diagnosed with IBD? 
o Adults  
o Children  





Q19 How frequently do you see patients diagnosed with IBD in your clinical practice? 
o Several times per week  
o Weekly  
o Fortnightly  
o Monthly  
o A few times a year  





Q20 Who refers patients with IBD to see you?  Select all that apply 
▢ Gastroenterologist/s  
▢ Paediatrician/s  
▢ GPs  
▢ Colorectal surgeon/s  
▢ IBD nurse/s  
▢ Practice nurse/s  
▢ Patient self-referral  
▢ Other (please describe) ________________________________________________ 
 
End of Block: GI patients 
 
Start of Block: Clinical practice 
Display This Question: 
If Do you see patients diagnosed with Inflammatory Bowel Disease (IBD)? = No 
 
Q21  
Thank you for completing this survey.   
 If you would like to go in the draw for a paid registration at the DNZ Gastro SIG study day in 2020 (or 2021 
if 2020 event is cancelled) to thank you for your time, please click on (or copy and paste) the link 




are separate from your survey responses.   
  
  
https://otago.au1.qualtrics.com/jfe/form/SV_2bDX1CtpssFOdnf   
 
    
  
 
Skip To: End of Survey If  Thank you for completing this survey.   If you would like to go in the draw for a paid 
registrati... Is Displayed 
 
Q22 Do you use a standardised nutrition assessment tool with IBD patients? 
o No  
o Yes, if so which one/s? ________________________________________________ 
 







Q24 How do you assess anthropometry in your IBD patients? Select all that apply 
▢ Weight  
▢ Height  
▢ BMI  
▢ Mid arm circumference  
▢ Waist circumference  
▢ Hand grip strength  
▢ Bioimpedance scales  





Q25 How often do you do this?  Select all that apply 
▢ Initial appointment  
▢ All follow-up appointments  
▢ Six monthly  
▢ Annually  
▢ When I think it is relevant  
▢ Other ________________________________________________ 
 
Q26 Do you routinely monitor biochemistry results when assessing IBD patients?  Select all that apply 
o Yes, always  
o Yes, when they are available  
o I cannot routinely access biochemistry results  
o I am not sure which tests are relevant  






Display This Question: 
If Do you routinely monitor biochemistry results when assessing IBD patients?  Select all that apply = Yes, 
always 
Or Do you routinely monitor biochemistry results when assessing IBD patients?  Select all that apply = Yes, 
when they are available 
 
Q27 Which three biochemistry tests do you consider the most important in nutritional assessment of IBD 
patients? 
▢ a) ________________________________________________ 
▢ b) ________________________________________________ 
▢ c) ________________________________________________ 
 










Q30 How do you assess dietary intake of IBD patients? Select all that apply 
▢ Food diary  
▢ Food recall  
▢ Food frequency questionnaire  
▢ Other, please describe ________________________________________________ 
 
Q31 How often do you do this?  Select all that apply 
▢ Initial appointment  
▢ All follow-up appointments  
▢ Six monthly  
▢ Annually  
▢ When I think it is relevant  
▢ Other ________________________________________________ 
 
End of Block: Clinical practice 
 




Q32 What type of nutrition interventions do you use with Crohn's disease patients?  Select all that apply 
▢ EEN with children (exclusive enteral/liquid formula nutrition)  
▢ EEN with adults (exclusive enteral/liquid formula nutrition)  
▢ PEN (partial enteral/liquid formula nutrition), providing at least 50% of total calories  
▢ Prescribing oral supplement drinks e.g. Fortisip, Ensure  
▢ Prescribing vitamin/mineral/electrolyte supplements  
▢ General nutrition advice  
▢ Specific diets e.g. low residue, low FODMAP, high protein/energy, high fibre, Crohn's 
disease exclusion, anti-inflammatory, Specific Carbohydrate, Mediterranean, LOFFLEX, semi-
vegetarian diet etc. Please list which diets you use with IBD patients 
________________________________________________ 
▢ Recommend natural products/supplements - please describe 
________________________________________________ 





Q33 What type of nutrition interventions do you use with Ulcerative Colitis patients?  Select all that apply 
▢ EEN with children (exclusive enteral/liquid formula nutrition)  
▢ EEN with adults (exclusive enteral/liquid formula nutrition)  
▢ PEN (partial enteral/liquid formula nutrition), providing at least 50% of total calories  
▢ Prescribing oral supplement drinks e.g. Fortisip, Ensure  
▢ Prescribing vitamin/mineral/electrolyte supplements  
▢ General nutrition advice  
▢ Specific diets e.g. low residue, low FODMAP, high protein/energy, high fibre, Crohn's 
disease exclusion, anti-inflammatory, Specific Carbohydrate, Mediterranean, LOFFLEX, semi-
vegetarian diet etc. Please list which diets you use with IBD patients 
________________________________________________ 
▢ Recommend natural products/supplements - please describe 
________________________________________________ 





Q34 Do you provide written advice to your IBD patients? 
o Yes, always  
o Usually  
o Sometimes  
o No  
 
End of Block: Block 6 
 
Start of Block: Workload and Capacity 
Q35 IBD prevalence is expected to continue increasing.  Could you see more IBD patients with your current 
FTE/workforce resourcing? 
▢ Yes, additional publicly funded appointments would be possible  
▢ Yes, additional privately funded appointments would be possible  
▢ Maybe  





Q36 Would you need to make changes to your service to be able to see more IBD patients? 
▢ No changes, or minor changes only  
▢ Decline other referrals to allow more IBD patients to be seen  
▢ Create additional clinic appointments  
▢ Reduce non-contact time  
▢ Other ________________________________________________ 
 
Q37 Do you feel adequately resourced to provide an appropriate level of follow-up to your IBD patients? 
o Yes  
o Partially - explain ________________________________________________ 





Q38 How long is a newly diagnosed paediatric IBD patient likely to be on the waiting list before seeing an 
outpatient dietitian in your service? 
▢ Less than one month  
▢ One - two months  
▢ Two - three months  
▢ Over three months  
▢ N/A I do not see paediatric IBD patients  





Q39 How long is a newly diagnosed adult IBD patient likely to be on the waiting list before seeing an 
outpatient dietitian in your service? 
▢ Less than one month  
▢ One - two months  
▢ Two - three months  
▢ Over three months  
▢ N/A I do not see adult IBD patients  
▢ Comments ________________________________________________ 
 
Q40 Does your service accept referrals for management of functional gastrointestinal symptoms in IBD 
patients? 
o Yes  
o No  
 
End of Block: Workload and Capacity 
 




Q41 Please respond to this statement:  I am confident that I am up to date with the nutritional 
management of IBD 
o Strongly agree  
o Somewhat agree  
o Neither agree nor disagree  
o Somewhat disagree  
o Strongly disagree  
 
Q42 What improvements, if any, would you like to see in your dietetic service to achieve best practice 






Q43 What would you require to enable these improvements? e.g. workforce development, changes in 









Q44 How confident are you that patients experience a positive benefit from your service? 
o Very confident  
o Confident  
o Unsure  
o Not at all confident  
 
Q45 Would you value more specific Australasian guidelines and protocols for nutritional assessment in 
inflammatory bowel disease? 
o Yes  
o Maybe  
o No, not necessary  
 






Q47 Would you value more specific Australasian guidelines and protocols for nutrition therapies in 
inflammatory bowel disease? 
o Yes  
o Maybe  
o No  
 
Q48 Why or why not? 
________________________________________________________________ 
 






Q50 Thank you for taking the time to assist in our research.  Results will be sent out via Crohn's and Colitis 
New Zealand, as well as Dietitians New Zealand.    
For additional reading regarding the nutritional management of IBD, here are some suggested links: 
  
 Dietary management of IBD - insights and advice. E Halmos & P Gibson 
  
 An Examination of Diet for the Maintenance of Remission in Inflammatory Bowel Disease. N Haskey & D 




    
    
If you would like to go in the draw for a paid registration at the DNZ Gastro SIG study day in 2020 (or 2021 
if 2020 event is cancelled) to thank you for your time, please click on the link below.  This will take you to 
a separate website to enter your email address so that your contact details are separate from your survey 
responses.   
    
https://otago.au1.qualtrics.com/jfe/form/SV_2bDX1CtpssFOdnf 
End of Block: Knowledge and skills 
 








Start of Block: Default Question Block 
 
Q1 Thank you for taking part in our survey. We would like to know your thoughts about dietetic services 
for patients with IBD. We are also surveying patients and dietitians. The information we gather will help 
to improve dietitian services for IBD patients in New Zealand. 
 
Q2  
Are you a....? 
o Gastroenterologist  
o Registrar  





Q3 What is your gender? 
o Male  
o Female  
o Prefer not to answer  
 
 
Q31 What year did you graduate medical school? 
________________________________________________________________ 
 
Q5 In which settings do you currently practise? Select all that apply 
▢ Public Hospital  
▢ Private Hospital/Clinic  
▢ Research  





Q6 Which DHB catchment area/areas do you work in? 
________________________________________________________________ 
 
Q7 Do you work with adult or paediatric patients? 
o Adult  
o Paediatric  
o Both  
 
Q27 Are you part of an IBD multidisciplinary team?  
i.e. a team which meets regularly to discuss IBD patients, or where several healthcare professions 
contribute to the development of a patient care plan, or where more than one health profession meets 
with the patient in the same clinic? 
o Yes  
o No  
o Unsure  
 
Skip To: Q10 If Are you part of an IBD multidisciplinary team?  i.e. a team which meets regularly to discuss IBD... = 
No 






Q28 Which health professions are part of your IBD multidisciplinary team? 
▢ Gastroenterologist  
▢ Registrar  
▢ Colorectal surgeon  
▢ Radiologist  
▢ Histopathologist  
▢ IBD nurse  
▢ Pharmacist  
▢ Psychologist  
▢ Physiotherapist  
▢ Dietitian  





Q29 Does your clinic routinely screen for malnutrition in IBD patients? 
o Yes  
o No  
o Unsure  
 
 
Display This Question: 
If Does your clinic routinely screen for malnutrition in IBD patients? = Yes 
 
Q30 What percentage of IBD patients are identified as malnourished / high risk of malnutrition? 
o < 10%  
o 10-25%  
o 25-50%  





Q10 Do you agree that patient diet and nutrition are relevant to managing Crohn's disease? 
o Strongly agree  
o Somewhat agree  
o Neither agree nor disagree  
o Somewhat disagree  
o Strongly disagree  
 
Q11 Do you agree that patient diet and nutrition are relevant to managing Ulcerative Colitis? 
o Strongly agree  
o Somewhat agree  
o Neither agree nor disagree  
o Somewhat disagree  





Q9 Do your patients ask you about food, diet or nutrition in relation to inflammatory bowel disease? 
o Yes  
o No  
 
Q12 Do you ever provide nutrition advice to your patients diagnosed with IBD? 
o Yes  
o No  
 




Q13 What nutrition advice do you provide to patients with IBD? Select all that apply 
▢ General nutrition advice  
▢ Modification of fibre intake  
▢ Advice to trial a particular type of diet e.g. low residue, low FODMAP, exclusion diet etc 
(please write which diet or diets you advise patients to trial) 
________________________________________________ 
▢ Recommend exclusive enteral (liquid) nutrition ie no solid food for several weeks  
▢ Recommend partial enteral (liquid) nutrition, replacing at least 2 meals per day  
▢ Prescribe supplement drinks e.g. Fortisip, Ensure  
▢ Prescribe vitamin/mineral/electrolyte supplements  
▢ Recommend natural products/supplements - please describe 
________________________________________________ 





Q14 Do you have access to a dietitian service in your area? Select all that apply 
▢ Yes, inpatient dietitian service  
▢ Yes, publicly funded outpatient dietitian service  
▢ Yes, privately funded outpatient dietitian service  
▢ No  
 
Skip To: Q25 If Do you have access to a dietitian service in your area? Select all that apply = No 
Q26 Is the dietitian service a specialist gastroenterology dietetic service (dietitian sees mostly gastro 
patients and may have had additional training) or a general dietetic service? 
o Gastroenterology dietetic service  
o General dietetic service  





Q15 Does your local publicly funded dietitian service have access criteria that affect access for IBD 
patients? 
o Yes  
o No  
o Unsure  
 
Q16 What proportion of IBD patients do you refer to see a dietitian, approximately? 
o None  
o less than 5%  
o 5-20%  
o 20-50%  
o 50-75%  
o over 75%  
 
Q25 Are there any barriers that exist in your area that stop greater numbers of patients seeing a dietitian 







Q17 For which reasons do you, or would you, refer patients to see a dietitian? Please select all that apply 
▢ Advice during an acute flare of disease  
▢ Advice for patients pre- or post-surgery  
▢ EEN (exclusive liquid nutrition)  
▢ PEN (partial liquid nutrition, >50% of calorie intake)  
▢ Advice due to patient losing weight or child growing poorly  
▢ Ongoing functional gastrointestinal symptoms when disease is in remission  
▢ To advise re exclusion diet  
▢ Concern as patient's diet is highly restricted  
▢ Micronutrient deficiencies e.g. iron deficiency  
▢ Patient has requested referral  





Q18 In your experience, do most IBD patients experience a positive benefit from seeing a dietitian? 
o Definitely yes  
o Probably yes  
o Maybe  
o Probably not  
o Definitely not  
 
Q19 Do you suggest other sources of diet/nutrition information to your IBD patients? 
o No  
o Yes - if so, which? ________________________________________________ 
 
Q20 In your opinion, are NZ dietitians well trained in the nutritional management of IBD? 
o Yes  
o Variable  





Q21 In your opinion, are there enough dietitians in your area to meet the nutrition advice needs of current 
numbers of IBD patients? 
▢ Yes  
▢ Unsure  
▢ No  
▢ Comments? ________________________________________________ 
 
Q22 In your opinion, would patients benefit from the development of more specific Australasian 
guidelines and protocols for the nutritional assessment and management of IBD? 
o Yes  
o Maybe  
o No  
Q23 Thank you for your time.  If you have any other comments about dietetic services for IBD patients or 
the role of nutrition in the treatment and management of IBD, please feel free to add these here. 
________________________________________________________________ 
________________________________________________________________ 






  H19/167 
 
Dr C Wall 
Department of Medicine (ChCh) 
University of Otago, Christchurch 
University of Otago Medical School 
Dear Dr Wall, 
I am again writing to you concerning your proposal entitled “Patient experience of dietetic care in 
the treatment and management of inflammatory bowel disease in New Zealand”, Ethics 
Committee reference number H19/167. 
Thank you to Nicky McCarthy, student investigator on the above project, for her email of 17th December 
2019 with response attached addressing the issues raised by the Committee. 
On the basis of this response, I am pleased to confirm that the proposal now has full ethical approval to 
proceed. 
Academic Services 
Manager, Academic Committees, Mr Gary Witte 




The standard conditions of approval for all human research projects reviewed and approved by the 
Committee are the following: 
Conduct the research project strictly in accordance with the research proposal submitted and granted 
ethics approval, including any amendments required to be made to the proposal by the Human Research 
Ethics Committee. 
Final report: A Final Report is required by the Committee upon completion of the study. The 
Final Report template can be found on the Human Ethics Web Page 
https://www.otago.ac.nz/council/committees/committees/HumanEthicsCommittees.html 
Adverse or unforeseen events: Inform the Human Research Ethics Committee immediately of 
anything which may warrant review of ethics approval of the research project, including: serious or 
unexpected adverse effects on participants; unforeseen events that might affect continued ethical 
acceptability of the project; and a written report about these matters must be submitted to the 
Academic Committees Office by no later than the next working day after recognition of an adverse 
occurrence/event. Please note that in cases of adverse events an incident report should also be made 
to the Health and Safety Office: 
http://www.otago.ac.nz/healthandsafety/index.html 
Discontinuation: Advise the Committee in writing as soon as practicable if the research project is 
discontinued. 
Amendments: Make no change to the project as approved in its entirety by the Committee, including 
any wording in any document approved as part of the project, without prior written approval of the 
Committee for any change. If you are applying for an amendment to your approved research, please 






Locality authorisation: Studies requiring locality authorisation, i.e. permission from the 
organisations at which the study is taking place or from which participants are being accessed, must be 
confirmed before the study commences. 
Approval period: Approval is for up to three years from the date of this letter. If this project has not 
been completed within three years from the date of this letter, re-approval or an extension of approval 
must be requested. If the nature, consent, location, procedures or personnel of your approved 
application change, please advise me in writing. 
Yours sincerely, 
 
Mr Gary Witte 
Manager, Academic Committees 
Tel: 479 8256 
Email: gary.witte@otago.ac.nz 
 c.c. Professor R Gearry  Head  Department of Medicine (ChCh) 
 
